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Previous work showed that the adapter protein
SH2B adapter protein 1 (SH2B1) (SH2-B) binds to
the activated form of the nerve growth factor (NGF)
receptor TrkA and is critical for both NGF-depen-
dent neurite outgrowth and maintenance. To iden-
tify SH2B1-regulated genes critical for neurite out-
growth, we performed microarray analysis of control
PC12 cells and PC12 cells stably overexpressing
SH2B1 (PC12-SH2B1) or the dominant-negative
SH2B1(R555E) [PC12-SH2B1(R555E)]. NGF-induced
microarray expression of Plaur andMmp10 genes was
greatlyenhanced inPC12-SH2B1cells,whereasNGF-
induced Plaur andMmp3 expression was substantially
depressed inPC12-SH2B1(R555E) cells. Plaur,Mmp3,
and Mmp10 are among the 12 genes most highly up-
regulated after 6 h of NGF. Their protein products
[urokinaseplasminogenactivator receptor (uPAR),ma-
trix metalloproteinase 3 (MMP3), andMMP10] lie in the
same pathway of extracellular matrix degradation;
uPARhasbeenshownpreviously tobecritical forNGF-
induced neurite outgrowth. Quantitative real-time PCR
analysis revealed SH2B1 enhancement of NGF induc-
tion of all three genes and the suppression of NGF
induction of all three when endogenous SH2B1 was
reduced using short hairpin RNA against SH2B1 and in
PC12-SH2B1(R555E) cells. NGF-induced levels of
uPAR and MMP3/10 and neurite outgrowth through
Matrigel (MMP3-dependent) were also increased in
PC12-SH2B1 cells. These results suggest that
SH2B1 stimulates NGF-induced neuronal differentia-
tion at least in part by enhancing expression of a spe-
cific subset of NGF-sensitive genes, including Plaur,
Mmp3, and/or Mmp10, required for neurite outgrowth.
(Molecular Endocrinology 22: 454–476, 2008)
NERVE GROWTH FACTOR (NGF) plays a criticalrole in the development of the peripheral nervous
system. This is especially true for sympathetic neu-
rons, which are overproduced during development
and are believed to compete for the limited quantities
of target-derived NGF for their survival; only the select
neurons that successfully innervate NGF-producing
target organs persist (1–3). Sympathetic neuron re-
quirement for NGF for survival has been well docu-
mented both in vitro and in vivo (reviewed in Refs. 4
and 5). However, due to the absolute NGF depen-
dence of sympathetic neurons for survival, it has been
difficult to assess the necessity for NGF on other as-
pects of sympathetic neuron development and func-
tion, such as axonal growth and target innervation.
The use of Bax knockout mice circumvented this prob-
lem. Deletion of Bax, a proapoptotic transcription fac-
tor, dramatically reduces trophic-factor deprivation-
induced apoptosis of both sensory and sympathetic
neurons (6). The sensory and sympathetic neurons
that die off in mice lacking NGF (NGF/) and the NGF
receptor TrkA (TrkA/) (7, 8) are able to persist when
those mice are crossed with the Bax/mice (9). In the
double knockout mice, axons from both sympathetic
and sensory neurons appear unable to reach their
targets, resulting in impaired target innervation (9–11).
Although experiments using these mice implicate NGF
as an essential signal required for normal axonal
growth of and peripheral target innervation by sympa-
thetic and sensory neurons in vivo, the actual mech-
anisms by which NGF elicits these effects are only
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beginning to be understood. Most of what we know
about NGF-induced neuronal differentiation and NGF
signal transduction events has come from the PC12
cell model. PC12 cells, derived from a rat pheochro-
mocytoma, can be induced to differentiate into sym-
pathetic neuron-like cells by NGF (12, 13). Upon ex-
posure to NGF, these cells first cease to proliferate.
They then exhibit somatic hypertrophy, acquire neu-
rites, and express neuronal-specific genes. The neu-
rite outgrowths are capable of forming typical looking
synapses with primary neurons from rat cortex (14). As
has been documented for sympathetic and sensory
neurons, once PC12 cells differentiate into a neuronal
phenotype, they depend on NGF for survival (for re-
view, see Ref. 15).
NGF initiation of neuronal differentiation starts with
NGF binding to its receptor tyrosine kinase TrkA and
activating TrkA. The activated TrkA autophosphory-
lates, and the phosphorylated tyrosines in the TrkA
cytoplasmic domain bind a number of different signal-
ing molecules and initiate a variety of downstream
signaling pathways implicated in neuronal differentia-
tion (16, 17). Binding proteins include Shc, phospho-
lipase C- (PLC-), fibroblast growth receptor sub-
strate 2 (Frs2, SNT), and CHK, a homolog of the
cytoplasmic tyrosine kinase CSK (control of Src ki-
nase). Binding of these and presumably other TrkA
binding proteins lead to the activation of phospho-
lipase C-/Ca2, nuclear factor-B, phosphatidylino-
sitol-3-kinase/Akt, Ras/Raf/MEK/ERK1 and -2; Jun N-
terminal kinase, p38, and atypical protein kinase C
pathways (reviewed in Refs. 18 and 19).
We and others identified the putative adapter/scaf-
fold protein SH2B adapter protein 1 (SH2B1) as one
of the signaling proteins that bind to the NGF-acti-
vated form of TrkA (20, 21). NGF promotes the rapid
association of SH2B1 with TrkA and subsequent
phosphorylation of SH2B1 on tyrosines as well as
serines/threonines (20–22). SH2B1 belongs to a family
of adapter proteins that also includes APS (SH2B2)
and Lnk (SH2B3) (23–25). SH2B1 family members
contain a pleckstrin homology domain, at least one
dimerization domain, and a C-terminal SH2 domain
(reviewed in Ref. 26); it is the SH2 domain that binds to
TrkA. The four known SH2B1 splice variants, , , ,
and , differ only in their C termini starting just past the
SH2 domain (21, 27, 28), suggesting that all isoforms
would be recruited to TrkA and would share many, but
perhaps not all, responses. SH2B1 has been impli-
cated in NGF-induced neurite outgrowth of PC12 cells
(20, 21). Thus, overexpression of SH2B1 or SH2B1
enhances NGF-induced neurite outgrowth in PC12
cells. In contrast, mutating a critical arginine
[SH2B1(R555E)] within the SH2 domain of SH2B1
that prevents SH2B1 from binding to and being
phosphorylated by TrkA blocks NGF-induced neurite
outgrowth of PC12 cells (21, 22). SH2B1 has also been
implicated in the NGF-dependent maintenance of ex-
plants of sympathetic cervical ganglia (20). Dissoci-
ated primary sympathetic neurons growing in NGF-
containing medium exhibit a reduced rate of survival
when anti-SH2B1 antibodies are introduced by tritu-
ration. Similarly, axonal processes are nearly elimi-
nated when an SH2B1 mutant that blocks SH2B1-
mediated signaling is introduced within explants of
sympathetic ganglia grown in the presence of NGF. In
contrast, NGF-treated neurons into which wild-type
SH2B1 is introduced thrive and have elaborate, long-
branching axonal processes.
The mechanism by which SH2B1 enhances neurite
outgrowth is unknown. Qian and Ginty (29) suggest that
SH2B1 potentiates NGF induction of autophosphoryla-
tion of TrkA, assessed using an antibody to phosphoty-
rosine 490 in TrkA, the binding site for Shc. Such a
generalized stimulation of TrkA activity by SH2B1 might
be expected to enhance the expression of all NGF-
sensitive genes. However, SH2B1 potentiation of
NGF induction of TrkA activity cannot explain the ability
of the dominant-negative SH2B1(R555E) to block
NGF-induced neurite outgrowth, because PC12-
SH2B1(R555E) cells did not exhibit decreased TrkA
autophosphorylation in general (21) or on tyrosine 490
(Maures, T., and C. Carter-Su, unpublished observation)
in response to NGF. The inability of SH2B1(R555E) to
inhibit NGF-induced tyrosyl phosphorylation of TrkA,
phospholipase C, or Shc or activation of ERKs 1 and 2
led us to hypothesize that SH2B1 may initiate a previ-
ously unknown NGF signaling pathway (21). SH2B1
contains both a nuclear export (30) and nuclear localiza-
tion signal (Maures, T., L. Chen, and C. Carter-Su, manu-
script in preparation). Experiments using truncated and
mutated forms of SH2B1, as well as the inhibitor of
nuclear export leptomycin B, revealed that both ectopi-
cally expressed and endogenous SH2B1 shuttle be-
tween the cytoplasm/plasmamembrane and the nucleus
(30). Unlike wild-type SH2B1, SH2B1 mutants with a
defective nuclear export (30) or import (Maures, T., L.
Chen, and C. Carter-Su, manuscript in preparation) sig-
nal are unable to enhance NGF-induced neurite out-
growth. Together, these findings led us to hypothesize
that whereas SH2B1 might have a modest stimulatory
effect onmultiple NGF-sensitive genes, therewould exist
a specific subset of genes important for neurite out-
growth that were particularly sensitive to SH2B1.
To determine whether SH2B1 regulates all or a
subset of NGF-responsive genes early in the NGF-
induced neuronal differentiation program, and at the
same time identify SH2B1-regulated genes important
for neurite outgrowth, we performed microarray anal-
ysis on cRNA prepared from NGF-treated PC12 cells
stably expressing SH2B1, SH2B1(R555E), or
SH2B1 vector. We identified both a subset of NGF-
responsive genes whose NGF-regulated expression is
enhanced substantially further by SH2B1 and/or sub-
stantially dampened by SH2B1(R555E) as well as a
subset of genes whose expression is not altered by
SH2B1 or SH2B1(R555E). We confirmed the NGF
and SH2B1 regulation of a subset of these SH2B1-
regulated genes using quantitative real-time PCR (QT-
PCR). We further characterized SH2B1 regulation of
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the proteins encoded by three of the genes most
highly up-regulated by NGF and whose NGF up-reg-
ulation appeared to depend upon SH2B1: Plaur,
Mmp3, and Mmp10, encoding urokinase plasminogen
activator receptor (uPAR), matrix metalloproteinase
(MMP)-3 (stromelysin-1; transin-1), and MMP10
(stromelysin-2; transin-2), respectively. These proteins
were of particular interest because uPAR has been
shown previously to be required for NGF-induced neu-
ronal differentiation, and MMP3 and MMP10 lie in the
same extracellular matrix (ECM) degradation pathway
as uPAR. Consistent with MMP3 being important for
neurite outgrowth and penetration through an ECM,
we showed that SH2B1 enhances neurite extension
through Matrigel. Finally, we confirmed a critical role
for endogenous SH2B1 in the expression of these
proteins using short hairpin RNA (shRNA) to SH2B1,
which was found to suppress NGF-induced expres-
sion of Plaur, Mmp3, and Mmp10.
RESULTS
Identification of a Subset of NGF-Responsive
Genes that Are Regulated by SH2B1
To determine whether SH2B1 regulates the expres-
sion of all or a subset of NGF-sensitive genes in cells
and at the same time identify SH2B1-regulated genes
important for neurite outgrowth, we performed a
global analysis of gene expression in pooled PC12
cells stably expressing green fluorescent protein (GFP)
(control cells), GFP-tagged wild-type SH2B1 (PC12-
SH2B1 cells) or GFP-tagged dominant-negative
SH2B1(R555E) [PC12-SH2B1(R555E) cells] treated
with or without 100 ng/ml NGF for 6 h. Microarray
analysis of control PC12 cells using the rat Affymetrix
gene chip RAE223A that detects about 15,900 known
genes and expressed sequence tags (ESTs) identified
511 genes and ESTs whose expression at least dou-
bled in response to NGF (Fig. 1 and supplemental
table S1, published as supplemental data on The En-
docrine Society’s Journals Online web site at http://
mend.endojournals.org). Expression of 79 known
genes more than tripled (Table 1). Microarray analysis
of control PC12 cells identified a similar number (513)
of genes whose expression was decreased by more
than 50% after NGF treatment (Fig. 1 and supplemen-
tal Table S2). Together, these microarray studies indi-
cate that NGF rapidly regulates (both positively and
negatively) the expression of about 1000 genes/ESTs,
many more than previously recognized.
Among the 511 genes/ESTs whose expression was
at least doubled by NGF in control cells, 34 of them
showed a further doubling in NGF induction in PC12-
SH2B1 cells (Fig. 1 and Table 2), whereas 153 of
them displayed a 50% or greater reduction in NGF-
dependent expression in PC12-SH2B1(R555E) cells
(Fig. 1). Only two known genes (Plaur and Glrx1) and
four ESTs fit both criteria [i.e. exhibit NGF induction
that was both enhanced by at least 100% in PC12-
SH2B1 cells and reduced by 50% or more in PC12-
SH2B1(R555E) cells] (Fig. 1 and Table 3).
Similarly, among the 513 genes/ESTs whose ex-
pression was down-regulated by NGF by at least 50%,
49 showed a substantially greater (at least a doubling
of the NGF inhibition seen in control cells) NGF-de-
pendent reduction in expression in PC12-SH2B1
cells (Fig. 1 and Table 4), whereas 105 exhibited a
substantially diminished (by 50%) NGF-dependent
decrease in expression in PC12-SH2B1(R555E) cells
(supplemental Table S4). None of the known genes
and only one EST fulfilled both of these criteria. The
finding that some, but not all, of the NGF-responsive
genes show enhanced responsiveness to NGF in
SH2B1-overexpressing cells and/or reduced respon-
siveness to NGF in SH2B1(R555E)-expressing cells
is consistent with SH2B1 enhancing the NGF-in-
duced regulation of expression of a subset of NGF-
responsive genes during neuronal differentiation.
Functional Classification of NGF-Responsive
Genes that Are Also Regulated by SH2B1
To obtain insight into the cellular processes that are
regulated by SH2B1, genes whose expression level
was induced or inhibited by greater than a factor of
two after treatment with NGF were grouped into gene
ontology categories using DAVID (database for anno-
tation, visualization, and integrated discovery) (31). For
each of the three different cell lines, an average of 76%
of input genes were categorized. As predicted given
NGF’s ability to promote neuronal differentiation, after
stimulation of control PC12 cells with NGF for 6 h, the
expression of genes associated with cell differentia-
tion, intracellular signaling cascade, cell death, orga-
nogenesis, and morphogenesis was enhanced (Fig.
2A). Compared with control cells, PC12-SH2B1 cells
had an increased number of NGF-induced genes over-
represented in all of the above-mentioned categories,
whereas PC12-SH2B1(R555E) cells had a decreased
number. Also as predicted from NGF’s ability to pro-
mote neuronal differentiation, genes whose expres-
sion in control PC12 cells was decreased by NGF by
more than 50% were associated with cell cycle, cell
proliferation, and cell migration (Fig. 2B). Overexpress-
ing SH2B1 increased the number of NGF-induced
genes overrepresented in all of the above-mentioned
categories, whereas overexpressing SH2B1(R555E)
reduced NGF-induced overrepresentation of genes in
all three categories. In addition, genes in the category
of cell differentiation were overrepresented in cells
overexpressing SH2B1 and to a lesser extent in cells
overexpressing SH2B1(R555E). These findings are
consistent with SH2B1 increasing NGF-induced neu-
ronal differentiation at least in part by enhancing NGF-
induced expression of a subset of genes whose prod-
ucts are implicated in morphogenesis, organogenesis,
cell survival, and intracellular signaling and by increas-
ing the degree of NGF inhibition of expression of a
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subset of genes whose products are implicated in cell
cycle progression, cell proliferation, and cell migration.
SH2B1(R555E) appears to play a dominant-negative
role with regard to a subset of NGF-regulated genes
that affect morphogenesis, organogenesis, cell sur-
vival, intracellular signaling, and cell differentiation,
consistent with the substantially decreased ability of
PC12-SH2B1(R555E) cells to differentiate into a neu-
ronal phenotype in response to NGF.
Novel SH2B1-Regulated Genes Likely to Be
Involved in Neuronal Differentiation
Because PC12-SH2B1 and PC12-SH2B1(R555E)
cells display substantially enhanced and impaired
neurite outgrowth, respectively, we reasoned that
genes whose expression pattern is substantially en-
hanced after NGF treatment and whose NGF en-
hancement is greatly increased in PC12-SH2B1 cells
and/or substantially decreased in PC12-SH2B1(R555E)
cells would be prime candidates for further investigation.
Seventeen known genes exhibited at least a doubling of
expression in response to NGF in control cells and at
least a further doubling in NGF-induced expression in
PC12-SH2B1 cells (Table 2). Of these 17 genes,
Mmp10 exhibited both the greatest NGF induction of
gene expression in control PC12 cells (NGF/NGF
38) and the greatest further enhancement (approxi-
mately seven times) upon overexpression of SH2B1.
Mmp10 encodes MMP10, a proteinase involved in the
A
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Fig. 1. SH2B1 Enhances a Subset of NGF-Responsive Genes
A, The expression of 511 genes and ESTs (588 probe sets) was at least doubled by treatment of control PC12 cells with NGF
(6 h, 100 ng/ml) (C/C 2). Among the 511 genes and ESTs, the NGF-induced expression of 34 genes and ESTs was enhanced
by at least 100% by overexpression of SH2B1, represented by the white circle (C/C 2 and S/C 2 where S S/S
and C  C/C). Among the 511 genes and ESTs, the NGF-induced expression of 153 genes was reduced by 50% or more
in cells overexpressing SH2B1(R555E), represented by the dark gray circle (C/C  2 and R/C  0.5 where R  R/R
and C  C/C). There were only two genes and four ESTs that matched both criteria, represented by the overlapping area
between the white and dark gray circles (C/C  2; S/C  2; R/C  0.5). B, The expression of 513 genes and ESTs (507
probe sets) was reduced by at least 50% by treatment with NGF (6 h, 100 ng/ml) (C/C 0.5). Among the 513 genes and ESTs,
the expression of 49 genes and ESTs was further reduced by overexpression of SH2B1, represented by the white circle (C/C
 0.5 and S/C  0.5). The NGF-induced inhibition of 105 genes and ESTs was, in addition, dampened by overexpression of
SH2B1(R555E), represented by the dark gray circle (C/C  0.5 and R/C  2). There was only one EST that matched both
criteria, represented by the overlapping area between the white and dark gray circles (C/C  0.5; S/C  0.5; R/C  2).
C, S, and R represent gene expression levels in control PC12, PC12-SH2B1, and PC12-SH2B1(R555E) cells, respec-
tively, in the absence of NGF. C, S and R represent gene expression levels in NGF-treated control PC12, PC12-SH2B1,
and PC12-SH2B1(R555E) cells, respectively. C  C/C; S  S/S; R  R/R.
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Table 1. NGF Induces Increases in Gene Expression in PC12 Cells
Gene Symbol Gene Title Unigene C/C
Mmp3 MMP3 Rn.32086 114.81
Crh CRH Rn.10349 56.80
Pai1 Serine (or cysteine) proteinase inhibitor, member 1 Rn.29367 46.58
Mmp10 MMP10 Rn.9946 38.02
Mmp13 MMP13 Rn.10997 22.90
Egr1 Early growth response 1 Rn.9096 21.60
Ca2a Carbonic anhydrase 2 Rn.26083 14.81
Scn6a Sodium channel, voltage-gated, type 6, -polypeptide Rn.54541 12.32
Fosl1 Fos-like antigen 1 Rn.11306 10.22
Plaur Plasminogen activator, urokinase receptor Rn.82711 9.78
Vrl1 Vanilloid receptor-like protein 1 Rn.44866 7.73
Vgf VGF NGF-inducible Rn.9704 7.15
Krt1–18 Keratin complex 1, acidic, gene 18 Rn.11104 6.78
Reta Ret protooncogene Rn.44178 6.66
Dusp6 Dual-specificity phosphatase 6 Rn.4313 6.61
Ania4 Activity and neurotransmitter-induced early gene protein 4 Rn.40517 6.41
Klf5 Kruppel-like factor 5 (intestinal) Rn.17478 5.50
Bmp1 Bone morphogenetic protein 1 (procollagen C-proetinase) Rn.87080 5.43
Giot2 Gonadotropin-inducible ovarian transcription factor 2 Rn.77686 5.19
Nid67 Putative small membrane protein NID67 Rn.8865 5.18
Glrx1a Glutaredoxin 1 (thioltransferase) Rn.1484 4.94
Ifrd1 Interferon-related developmental regulator 1 Rn.3723 4.90
LOC286921 Aldose reductase-like protein Rn.23676 4.83
Tage4 Tumor-associated glycoprotein pE4 Rn.10677 4.83
Tjp2 Tight junction protein 2 Rn.10965 4.70
Gpr37 G protein-coupled receptor 37(endothelin receptor type B-like) Rn.28035 4.69
Tub Tubby (mouse) homolog Rn.30017 4.66
Tfpi Tissue factor pathway inhibitor Rn.15795 4.56
Prkaa2 AMP-activated protein kinase Rn.64583 4.48
Pcscl Peroxisomal Ca-dependent solute carrier-like protein Rn.17644 4.47
Cga Glycoprotein hormones, -subunit Rn.10589 4.22
Ctsk Cathepsin K Rn.5598 4.20
Ager Advanced glycosylation end product-specific receptor Rn.9829 4.10
Scya2 Small inducible cytokine A2 Rn.4772 4.10
Fgf15 Fibroblast growth factor 15 Rn.81230 4.04
Arc Activity-regulated cytoskeletal-associated protein Rn.10086 3.98
Lnk Linker of T-cell receptor pathways Rn.11228 3.98
Bat3a HLA-B-associated transcript 3 Rn.22304 3.97
Itga1 Integrin, 1 Rn.91044 3.87
Hes1 Hairy and enhancer of split 1 (Drosophila) Rn.19727 3.87
Ptafr Platelet-activating factor receptor Rn.10137 3.80
Lgals3 Lectin, galactose binding, soluble 3 Rn.764 3.79
Rgs5 Regulator of G-protein signaling 5 Rn.1150 3.78
Glrx1 Glutaredoxin 1 (thioltransferase) Rn.1484 3.77
Synd1 Syndecan Rn.11176 3.74
S100a10 S-100-related protein, clone 42C Rn.4083 3.69
Ak4 Adenylate kinase 4 Rn.44288 3.68
Scamp5 Secretory carrier membrane protein 5 Rn.24420 3.66
Rdc1 Chemokine orphan receptor 1 Rn.12959 3.65
Bdnfa Brain-derived neurothrophic factor Rn.11266 3.59
Filip Filamin-interacting protein L-Filip Rn.44931 3.59
Cdkn1a Cyclin-dependent kinase inhibitor 1A Rn.10089 3.57
Ptgs1 Prostaglandin-endoperoxide synthase 1 Rn.44404 3.51
Hpx Hemopexin Rn.2380 3.50
Ecel1 Endothelin converting enzyme-like 1 Rn.45803 3.47
Hk2 Hexokinase 2 Rn.91375 3.44
Clcn2 Chloride channel 2 Rn.11073 3.39
Upb1 Ureidopropionase,  Rn.11110 3.38
Snk Serum-inducible kinase Rn.12100 3.38
Nr2f6 Nuclear receptor subfamily 2, group F, member 6 Rn.25840 3.35
Junb Jun B protooncogene Rn.15806 3.32
Prss11 Protease, serine, 11 Rn.2782 3.32
(Table continues)
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degradation of the ECM (reviewed in Ref. 32). Among
these same 17 genes, only Plaur andGlrx1 (highlighted in
Table 2) also exhibited a significantly reduced (50%
reduction) response to NGF in PC12-SH2B1(R555E)
cells compared with control cells. Plaur and Glrx1 en-
code uPAR and glutaredoxin 1, respectively. Plaur was
of particular interest because of its being identified pre-
viously as a primary response gene for NGF critical for
Table 2. NGF-Responsive Genes Whose Expression Is Enhanced by SH2B1b
Gene Symbol Gene Title Unigene C/C S/S R/R S/C R/C
Mmp10 MMP10 Rn.9946 38.02 271.78 45.24 7.15 1.19
Stc1 Stanniocalcin 1 Rn.10647 3.12 20.87 2.05 6.69 0.66
Plaur Plasminogen activator, urokinase receptor Rn.82711 9.78 56.16 4.44 5.74 0.45
Scn6a Sodium channel, voltage-gated, type 6,  polypeptide Rn.54541 12.32 65.40 23.36 5.31 1.90
Ca2a Carbonic anhydrase 2 Rn.26083 14.81 76.20 7.90 5.13 0.55
Fosl1 Fos-like antigen 1 Rn.11306 10.22 48.84 5.48 4.78 0.54
Arc Activity-regulated cytoskeletal-associated protein Rn.10086 3.98 14.44 6.85 3.62 1.72
Glrx1a Glutaredoxin 1 (thioltransferase) Rn.1484 4.94 17.82 1.90 3.57 0.41
Dusp6 Dual-specificity phosphatase 6 Rn.4313 6.61 17.73 7.45 2.68 1.13
LOC286921 Aldose reductase-like protein Rn.23676 4.83 12.78 4.80 2.64 0.99
Ania4 Activity- and neurotransmitter-induced early gene protein 4 (ania-4) Rn.40517 6.41 14.77 7.42 2.30 1.16
Egr1 Early growth response 1 Rn.9096 21.60 49.52 27.71 2.29 1.28
Kzf2 KRAB-zinc finger protein KZF-2 Rn.10664 2.02 4.62 2.03 2.29 1.01
Tage4 Tumor-associated glycoprotein pE4 Rn.10677 4.83 10.70 4.29 2.22 0.89
Basp2 Brain abundant, membrane-attached signal protein 2 Rn.10928 2.23 4.64 1.40 2.08 0.63
Gprk5 G protein-coupled receptor kinase 5 Rn.6500 2.10 4.33 1.70 2.06 0.81
Bcl10 B-cell CLL/lymphoma 10 Rn.13007 2.20 4.51 2.03 2.05 0.92
Control PC12, PC12-SH2B1, or PC12-SH2B1(R555E) cells were incubated with vehicle or NGF for 6 h, and gene expression
profiles were assessed as described inMaterials and Methods. Gene symbols, gene titles, and unigene numbers are listed for the
17 known genes for which NGF induces at least a doubling of expression in control PC12 cells (C/C 2) and at least a further
doubling of NGF-induced expression in PC12-SH2B1 (S/C 2), arranged in order of decreasing ability of SH2B1 to enhance
NGF-induced gene expression. An additional 18 ESTs (unlisted) met this criterion. Two genes, Plaur and Glrx1 (and four ESTs not
listed), additionally show a reduction in the magnitude of NGF induction of expression in PC12-SH2B1(R555E) cells to a level
that is less than 50% that seen with control PC12 cells (R/C  0.5). C, C, S, S, R, R, C, S, and R are defined
in Fig. 1. The sorting criterion of the table is designated in bold.
a Genes represented by more than one probe set; values listed are the average of the replicates.
Table 1. Continued
Gene Symbol Gene Title Unigene C/C
Mmp3 MMP3 Rn.32086 114.81
Adcyap1r1 Adenylate cyclase activating polypeptide 1 receptor 1 Rn.88408 3.32
Lasp1 LIM and SH3 protein 1 Rn.69815 3.30
Ehd4 Pincher Rn.7379 3.29
Msg1 Melanocyte-specific gene 1 protein Rn.8163 3.26
Gls Glutaminase Rn.5762 3.23
Axcam Axonal-associated cell adhesion molecule Rn.10117 3.17
Dcamkl1 Double cortin and calcium/calmodulin-dependent protein kinase-like 1 Rn.80575 3.16
Stc1 Stanniocalcin 1 Rn.10647 3.12
Cyp4a12 Cytochrome P450, 4a12 Rn.10034 3.08
S100a4 S100 calcium-binding protein A4 Rn.504 3.06
LOC59314 CaM-KII inhibitory protein Rn.42880 3.06
Slc6a2 Solute carrier family 6(neurotransmitter transporter, noradrenalin),member 2 Rn.14577 3.05
Thrsp Thyroid hormone responsive protein (spot14) Rn.81140 3.04
Tceb3 Transcription elongation factor B (SIII), polypeptide 3 (110 kDa) Rn.37427 3.04
Anxa2 Calpactin I heavy chain Rn.28 3.04
Crmp4 Collapsin response mediator protein 4 Rn.8499 3.01
Control PC12 cells were incubated for 0 or 6 h with 100 ng/ml NGF, and gene expression profiles were assessed as described in
Materials and Methods. Gene symbols, gene titles, and unigene numbers are listed for the 77 known genes exhibiting NGF-induced
gene expression of at least three times basal (no NGF) in control PC12 cells (C/C 3), arranged in descending order based on the
magnitude of the NGF induction of expression. The 74 ESTs that met this criterion are included in supplemental table S1. C and C
indicate gene expression levels in untreated and NGF-treated control PC12 cells, respectively.
a Genes represented by more than one probe set; values listed are the average of the replicates.
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NGF-induced neurite outgrowth and biochemical differ-
entiation of PC12 cells (33, 34). Glutaredoxin 1 has not
been previously shown to be up-regulated by NGF,
much less by SH2B1, but was intriguing because it is
found in neurons and modulates cellular redox status,
important for cell survival against oxidative stress (35).
In addition, there were 12 genes whose NGF-in-
duced level of expression in PC12-SH2B1 cells did
not meet our criterion of being substantially greater (at
least a doubling) than in control cells but whose NGF-
induced expression was substantially reduced (by
50%) in PC12-SH2B1(R555E) cells [1  (S/S)/
(C/C)  2; (R/R)/(C/C)  0.5] (Table 3).
Among those genes, Mmp3 exhibited the greatest
NGF induction of expression in control PC12 cells
(NGF/NGF 115) as well as one of the greatest
reductions (68%) in NGF-stimulated expression in
PC12-SH2B1(R555E) cells. Mmp3 was of interest
because it encodes MMP3, a proteolytic enzyme
present in growth cones of NGF-treated PC12 cells
and previously implicated in neurite penetration
through the ECM (36).
NGF inhibits the expression of almost as many
genes as it enhances the expression of, suggesting
Table 4. Genes Whose Expression Is Suppressed by NGF and Further Suppressed by SH2B1b
Gene Symbol Gene Title Unigene C/C S/S R/R S/C R/C
Pola2 DNA polymerase -subunit II Rn.31773 0.44 0.10 0.30 0.23 0.69
Sord Sorbitol dehydrogenase Rn.11334 0.13 0.04 0.12 0.28 0.89
Gcgr Glucagon receptor Rn.11225 0.24 0.07 0.30 0.31 1.23
Prkwnk4 Protein kinase, lysine deficient 4 Rn.12652 0.49 0.17 0.82 0.34 1.66
Ga Liver mitochondrial glutaminase Rn.10202 0.47 0.16 0.37 0.35 0.80
Hip1 Huntingtin interacting protein 1 Rn.50506 0.47 0.17 0.59 0.35 1.24
Syt3 Synaptotagmin 3 Rn.48884 0.28 0.11 0.46 0.38 1.63
Rb2a Retinoblastoma-related gene Rn.11020 0.39 0.15 0.43 0.39 1.10
Cldn3 Claudin 3 Rn.4513 0.48 0.19 0.48 0.40 1.01
U91561 Pyridoxine 5-phosphate oxidase Rn.6299 0.45 0.20 0.40 0.44 0.89
Rab3a Ras-related small GTP binding protein 3A Rn.44409 0.37 0.17 0.46 0.46 1.26
Pold1 DNA polymerase , catalytic subunit Rn.88690 0.27 0.13 0.32 0.48 1.21
Control PC12, PC12-SH2B1, or PC12-SH2B1(R555E) cells were incubated with vehicle or 100 ng/ml NGF for 6 h, and gene
expression profiles were assessed as described in Materials and Methods. Gene symbols, gene titles, and unigene numbers are
listed for the 12 known genes whose expression in control cells is both reduced by NGF treatment to less than 50% of basal levels
(C/C  0.5) and whose NGF-induced reduction is further reduced by at least an additional 50% in PC12-SH2B1 cells
(C/C  0.5; S/C  0.5), arranged in the order of decreasing SH2B1-dependent inhibition of gene expression (decreasing
S/C). Thirty-four ESTs (not listed) fulfilled these criteria. C, C, S, S, R, R, C, S, and R are defined in Fig. 1. The
sorting criterion of the table is designated in bold.
a Genes represented by more than one probe set; values listed are the average of the replicates.
Table 3. NGF-Responsive Genes Whose Expression Is Inhibited by SH2B1(R555E)
Gene Symbol Gene Title Unigene C/C S/S R/R S/C R/C
Pai1 Serine (or cysteine) proteinase inhibitor, member 1 Rn.29367 46.58 53.54 7.63 1.15 0.16
Vldlr Very-low-density lipoprotein receptor Rn.9975 2.25 2.35 0.65 1.04 0.29
Klf5 Kruppel-like factor 5 (intestinal) Rn.17478 5.50 10.64 1.76 1.93 0.32
Mmp3 MMP3 Rn.32086 114.81 119.00 37.17 1.04 0.32
Pou2f1 POU domain, class 2, transcription factor 1 Rn.9992 2.24 3.38 0.78 1.51 0.35
Bcat1 Branched-chain aminotransferase 1, cytosolic Rn.8273 2.73 3.72 1.00 1.36 0.37
Cryab Crystallin, B Rn.54554 2.28 2.32 0.92 1.02 0.40
Ecel1 Endothelin converting enzyme-like 1 Rn.45803 3.47 5.57 1.43 1.61 0.41
Glrx1a Glutaredoxin1 (thioltransferase) Rn.1484 4.94 17.82 1.90 3.57 0.41
Msg1 Melanocyte-specific gene 1 protein Rn.8163 3.26 3.46 1.36 1.06 0.42
TA1 Tumor-associated protein 1 Rn.32261 2.18 3.11 0.93 1.43 0.42
Nmrk Non-MHC-restricted killing associated Rn.53994 2.24 2.44 1.00 1.09 0.45
Plaur Plasminogen activator, urokinase receptor Rn.82711 9.78 56.16 4.44 5.74 0.45
Sv2b Synaptic vesicle glycoprotein 2b Rn.9940 2.30 2.84 1.07 1.23 0.47
Control PC12, PC12-SH2B1, or PC12-SH2B1(R555E) cells were incubated with vehicle or NGF for 6 h, and gene expression
profiles were assessed as described inMaterials and Methods. Gene symbols, gene titles, and unigene numbers are listed for the
14 known genes whose NGF-induced expression was at least doubled in control cells (C/C  2), greater in PC12-SH2B1
cells than in control PC12 cells (S/C 1), and reduced in PC12-SH2B1(R555E) cells to a level that is less than 50% that seen
with control PC12 cells (R/C  0.5), arranged in order of decreasing ability of SH2B1(R555E) to impair NGF-induced gene
expression (decreasing R/C). An additional 11 ESTs (unlisted) met this criterion. C, C, S, S, R, R, C, S, and R
are defined in Fig. 1. The sorting criterion of the table is designated in bold.
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that for neuronal differentiation to occur, reduction
of gene expression is as important as enhancement
of gene expression. Twelve known genes exhibited
more than a 50% decrease in expression in re-
sponse to NGF in control cells and a further 50% or
greater decrease in NGF responsiveness in PC12-
SH2B1 cells (Table 4). Consistent with SH2B1
enhancing NGF-induced neuronal differentiation, a
process associated with decreased cellular prolifer-
ation, this group of down-regulated genes includes
two that encode for proteins involved in DNA repli-
cation: Pola2 (polymerase -subunit II) and Pold1
(DNA polymerase , catalytic subunit). Polymerase
-subunit is required for DNA replication, whereas
DNA polymerase  possesses 3 exonuclease activ-
ity that is important for repair during DNA replication
(37). Expression of SH2B1(R555E) dampened
NGF-induced inhibition of expression of only one
EST. Dampening of NGF-induced expression of no
known genes (supplemental Table S4) achieved our
predetermined criterion of at least 50%.
SH2B1 Increases the Expression of a Subset of
NGF-Responsive Genes
To systematically identify genes whose expression was
substantially increased in response to NGF and whose
NGF-induced expression was further substantially in-
creased by overexpression of SH2B1 and/or substantially
dampened by overexpression of SH2B1(R555E), we ap-
plied a hierarchical clustering algorithm based on Pearson
correlation coefficients to group genes based on the simi-
larity of NGF-dependent expression patterns among the
three stable cell lines (Fig. 3). Red represents increased
mRNA levels, green denotes decreased mRNA levels, and
color intensity represents the magnitude of the expression
ratio. This analysis revealed, in addition to Plaur and Glrx1,
which met our most stringent criteria of opposing 2-fold or
greater differences in NGF-regulated gene expression in
PC12-SH2B1andPC12-SH2B1(R555E) cells vs.control
PC12 cells, several genes whose regulation followed the
same pattern but did not quite meet the criteria of at least
2-fold differences (in opposing directions) for both PC12-
SH2B1 and PC12-SH2B1(R555E) cells. NGF-regulated
(known) genes that fit both of our criteria [greatly increased
NGF induction in PC12-SH2B1 cells and significantly re-
duced NGF induction in PC12-SH2B1(R555E) cells] in-
clude Fosl1 (encoding Fos-like antigen 1), Plaur (uPAR),
Ca2 (carbonic anhydrase 2), Pai1 (serine or cysteine pro-
teinase inhibitor, member 1), Stc1 (stanniolcalcin 1), Glrx1
(glutaredoxin 1), and Klf5 (kruppel-like factor 5). NGF-sen-
sitive genes fitting just one of the criteria [increased NGF
responsiveness in PC12-SH2B1 cells or decreased re-
sponsiveness in PC12-SH2B1(R555E) cells compared
withcontrol cells] includedMmp10 (increasedNGF respon-
siveness in PC12-SH2B1 cells) andMmp3andCrh (CRH)
(decreased responsiveness in PC12-SH2B1(R555E)
cells). The NGF-induced expression (NGF/NGF) for
genes representing each of these categories is listed in Fig.
3B. NGF-induced expression of Scn6a (sodium channel,
voltage-gated, type 6, -polypeptide) and Egr1 (early gene
response 1) was also greatly enhanced in PC12-SH2B1
cells comparedwith control cells, but these geneswere not
explored further because their NGF-induced expression
was also enhanced, albeit to a lesser extent, in PC12-
SH2B1(R555E) cells.
QT-PCR Confirms SH2B1 Enhancement of
Expression of NGF-Regulated Genes Identified
Using Microarray Analysis
To confirm NGF and SH2B1 regulation of expression
of genes identified from the Affymetrix gene array
analysis, we performed QT-PCR on representative
genes from among the above genes showing by hier-
archical clustering algorithm significantly increased
(four to seven times greater) NGF-induced expression
in PC12-SH2B1 cells vs. control cells (Mmp10), sub-
stantially decreased (by 33–68%) NGF-induced ex-
pression in PC12-SH2B1(R555E) cells vs. control
cells (Mmp3), or both (Plaur, Ca2, Stc1, and Glrx1)
(Fig. 3C). In general, the levels of NGF-induced gene
Fig. 2. Functional Classification of NGF-Responsive Genes
in Control PC12, PC12-SH2B1, and PC12-SH2B1(R555E)
Cells
Genes that were either up-regulated to at least twice the
basal value by NGF (A) or down-regulated more than 50% by
NGF (B) in control PC12, PC12-SH2B1, and PC12-
SH2B1(R555E) cells were grouped into gene ontology cat-
egories. Overrepresented categories with P  0.05 are
shown.
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Fig. 3. NGF-Responsive Genes that Are Highly Regulated by SH2B1
A, NGF-induced gene expression profiles in control PC12 (C), PC12-SH2B1 (SH2B1), and PC12-SH2B1(R555E) (R555E)
cells were clustered and visualized using Eisen software (http://rana.lbl.gov/EisenSoftware.htm). Four different clusters of genes
that show NGF-induced gene expression in all three cell types are shown. For each gene, black represents the average value of
all six probe sets. The relative intensity of red represents the degree of increased mRNA levels, and the relative intensity of green
represents the degree of decreased mRNA levels. The number of arrows represents the relative levels of increase. B, Microarray
data for selected genes from each of the four clusters. C, Gene expression levels for six of the genes shown in A were verified
by QT-PCR, normalized first to levels of GAPDH gene expression and then to levels of gene expression seen in control PC12 cells
treated with NGF. Means 	 SEM from three to four experiments are shown. *, Statistically significant differences (P  0.05) using
a one-tailed, paired Student’s t test.
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expression in PC12-SH2B1 cells or PC12-
SH2B1(R555E) cells relative to control cells deter-
mined by QT-PCR paralleled those found by microar-
ray analysis. Thus, the expression of all six genes
was substantially increased in response to NGF in
control PC12 cells. Also as predicted, compared with
control cells, the NGF-stimulated response was
substantially greater in PC12-SH2B1 cells for Plaur,
Ca2, Stc1, Glrx1, and Mmp10 and lower in PC12-
SH2B1(R555E) cells for Plaur, Ca2, Glrx1, and
Mmp3. In addition, NGF-induced expression was
modestly greater in PC12-SH2B1 cells than in con-
trol cells for Mmp3 and modestly lower in PC12-
SH2B1(R555E) cells vs. control cells for Mmp10.
Thus, all six of the genes showed an increased NGF-
induced expression when SH2B1 was overex-
pressed, and five of the six genes showed decreased
NGF-induced expression when the dominant-negative
SH2B1(R555E) was expressed, consistent with these
genes being regulated by SH2B1 and mediating at
least in part SH2B1’s effect on NGF-induced neuronal
differentiation.
Time Course of NGF-Induced Expression of
SH2B1-Regulated Genes
To determine whether overexpression of SH2B1 in-
creases overall NGF-induced expression of genes or
simply shifts the time course of NGF-induced changes
in expression, we used QT-PCR to compare the time
course of NGF inducement of expression of Stc1,
Plaur, Mmp3, Mmp10, Ca2, and Glrx1 genes in control
and PC12-SH2B1 cells (Fig. 4). For all genes tested,
the time of onset of NGF-induced gene expression
appeared similar in control and PC12-SH2B1 cells.
Similarly, expression of all tested genes was elevated
at multiple time points in PC12-SH2B1 compared
with control cells, and the majority of the tested genes
had their highest level of induction at 4 or 6 h in both
control and PC12-SH2B1 cells. Thus, for no gene
could the difference in level of NGF induction in PC12-
SH2B1 cells compared with control cells seen after
6 h of NGF be attributed to a different time course of
NGF responsiveness. However, it is interesting to note
that NGF-induced expression of both Mmp3 and
Mmp10 was prolonged in PC12-SH2B1 cells com-
pared with control cells. In contrast to control cells in
which Mmp3 and Mmp10 expression declined to near
basal values after 24 h of NGF, Mmp3 and Mmp10
expression in PC12-SH2B1 cells remained elevated
(Mmp3) or may have even been still rising (Mmp10)
after 24 h. These data indicate that SH2B1 both
enhances and prolongs NGF induction of expression
of a subset of NGF-sensitive genes.
Effect of SH2B1 on NGF-Induced uPAR Protein
Level and uPAR Subcellular Distribution
Strikingly, proteins encoded by three of the genes
showing the greatest induction by NGF at 6 h as well
as the greatest enhancement of that induction by
SH2B1 or diminishment of that induction by
SH2B1(R555E) (uPAR, MMP3, and MMP10) fall in
the same protease cascade (Fig. 5). In this cascade,
uPAR binds the enzymatically inactive proform of
urokinase plasminogen activator (pro-uPA), allowing
it to be cleaved by cathepsins and thereby acti-
vated. The activated uPA proteinase subsequently
cleaves inactive plasminogen to form enzymatically
active plasmin, which in turn cleaves inactive pro-
MMPs to form enzymatically active MMPs. This cas-
cade has been implicated in neurite outgrowth and
more generally in cell differentiation, tissue remod-
eling, cell invasiveness, and wound healing (re-
viewed in Refs. 38 and 39). Because of the high level
of both NGF and SH2B1 regulation of gene expres-
sion for uPAR, MMP3, and MMP10, the identifica-
tion of Plaur as a primary response gene, and the
previously documented critical role of uPAR in NGF-
induced neuronal differentiation, we studied further
the effect of SH2B1 on uPAR, MMP3, and MMP10.
To confirm that the changes in NGF-induced Plaur
gene expression levels seen in PC12-SH2B1 and
PC12-SH2B1(R555E) cells results in correspond-
ing changes in the levels of uPAR protein, we ex-
amined levels of uPAR protein in control, PC12-
SH2B1, and PC12-SH2B1(R555E) cells by both
Western blot and immunocytochemistry. In Western
blots of lysates from control cells, 4 h of NGF treat-
ment transiently increased levels of uPAR protein
(Fig. 6A). In PC12-SH2B1 cells, NGF increased
levels of uPAR protein at both 4 and 6 h, with the 6-h
levels being significantly greater than in control
cells. Compared with control cells, PC12-
SH2B1(R555E) cells showed reduced levels of
both basal and NGF-induced uPAR protein at all
time points. Levels of expression of SH2B1 and
SH2B1(R555E) were similar to each other and all
three cell lines expressed similar levels of actin,
indicating that the differences seen in uPAR levels
were not due to differences in the amount of protein
loaded. The reason the magnitude of the uPAR sig-
nal in PC12-SH2B1 cells relative to control PC12
cells was lower than what the gene expression stud-
ies would predict is not known. However, the fact
that the difference in levels in NGF-induced protein
expression between control and SH2B1 PC12 cells
is greatest at 6 h raises the possibility that even
greater differences would be detectable at later
times.
To confirm the relative levels of NGF-induced uPAR
expression and to determine whether SH2B1 affects
the spatial distribution of uPAR, we immunostained
control PC12, PC12-SH2B1, and PC12-SH2B1(R555E)
cells for uPAR after 0, 7, or 24 h of 100 ng/ml NGF. Immu-
nostaining was performed under nonpermeabilizing condi-
tions to allow better visualization of uPAR associated with
the plasma membrane. In all three cell lines, uPAR was
observed at the cell surface in adhesion complex-like
puncta (Fig. 6, G, I, K, M, and O), consistent with uPAR
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being a glycosylphosphatidylinositol-linked protein and its
known interaction with proteins (e.g. integrins) in adhesion
complexes (reviewed in Ref. 40). In all three cell lines,
plasma membrane uPAR was present throughout the cell
body of the neurite and at growth cones (Fig. 6, G, I, K, and
M, and a darker exposure of Fig. 6O, data not shown). NGF
treatment increased levels of uPAR at the plasma mem-
brane of PC12-SH2B1 cells at both 7 and 24 h (compare
Fig. 6G and 6I to 6E) as well as in control and
SH2B1(R555E) cells (data not shown). At 24 h after NGF
addition, plasma membrane uPAR immunostaining was
clearly greater in PC12-SH2B1 cells (Fig. 6L) and lower in
PC12-SH2B1(R555E) cells (Fig. 6O) than in control PC12
cells (Fig. 6K). Thepreviously reported requirement of uPAR
for NGF-induced neurite outgrowth (33) combined with the
ability of SH2B1 to greatly enhance both expression of
Plaur gene and plasma membrane levels of uPAR protein
reported here suggest that SH2B1 enhancesNGF-induced
Fig. 4. Time Course of SH2B1 Enhancement of Expression of Representative NGF-Regulated Genes
Control PC12 or PC12-SH2B1 cells were treated with 100 ng/ml NGF for 0 or 30 min or 1, 2, 4, 6, or 24 h. Relative gene
expression levels were determined using QT-PCR and normalized to levels of GAPDH gene expression.
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neurite outgrowth at least in part bymediating or enhancing
the NGF-induced expression of Plaur.
NGF-Induced MMP3/10 Activity Is Elevated in
PC12-SH2B1 Cells and Suppressed in
PC12- SH2B1(R555E) Cells
We next examined the effect of NGF and SH2B1 on
the protease activity of MMP3 and MMP10. Because
of their similar size and substrate specificity and in the
absence of immunoprecipitating antibodies that could
distinguish between MMP3 and MMP10, we assayed
MMP3 and MMP10 together. Conditioned medium
was collected from cells treated with 100 ng/ml NGF
for various times, concentrated, and assayed for the
presence of MMP3 and MMP10 using a zymogram gel
containing casein as substrate. When purified human
MMP3 was used as a positive control, as expected, a
cleared band was observed at Mr approximately
50,000 (nonreducing condition), consistent with
MMP3 degrading the casein (Fig. 7A). Rat MMP3 mi-
grates as a 60-, 62-kDa doublet under reducing con-
ditions. It was therefore expected to migrate slightly
slower than human MMP3 (41). MMP3 and MMP10
are approximately the same size and cannot be differ-
entiated in this assay. By 6 h of NGF treatment, control
cells showed noticeable NGF-induced casein-degrad-
ing activity at a molecular weight consistent for MMP3/
10. This protease activity continued to increase with
increasing incubation times (8 and 10 h) with NGF.
Consistent with SH2B1 increasing NGF-induced lev-
els of Mmp3/Mmp10 gene expression, this NGF-de-
pendent protease activity was greater in magnitude in
NGF-treated PC12-SH2B1 cells and substantially
decreased in magnitude in NGF-treated PC12-
SH2B1(R555E) cells compared with control cells.
SH2B1 Enhances NGF-Induced Neurite
Outgrowth of PC12 Cells through Matrigel
Like uPAR activity, MMP3 activity has been associ-
ated with neurite outgrowth. However, unlike uPAR, its
down-regulation (by use of antisense RNA) did not
affect the number or length of neurites produced by
PC12 cells on a two-dimensional tissue culture sur-
face. Rather, down-regulation of MMP3 blocked the
ability of neurites to penetrate through a Matrigel bar-
rier (36). Combined with the finding that SH2B1 en-
hances the activity of MMP3/10, this latter finding
suggests that SH2B1 should enhance growth cone
migration and invasion through an ECM barrier. To test
this, control PC12 cells and PC12-SH2B1 cells were
plated onto the cis-plane of a transwell membrane
overlaid with growth factor-reduced Matrigel (Fig. 8A).
NGF (100 ng/ml) was added every other day to the
outer chamber for 4 d. Cells were then fixed and
immunostained for neuronal -tubulin. Neurites that
traversed to the trans-plane of the membrane were
counted. The number of neurites that invaded through
the Matrigel to the trans-plane in cells expressing
GFP-SH2B1 was found to be over twice (230%) the
number of invading neurites from control cells (Fig.
8B). The neurons themselves were found not to tra-
verse the trans-plane of the membrane.
Inhibition of SH2B1 Suppresses NGF-Induced
Expression of Plaur, Mmp3, and Mmp10
The ability of overexpression of wild-type SH2B1 to
enhance and the dominant-negative SH2B1(R555E)
to inhibit NGF-induced expression of Plaur, Mmp3,
and Mmp10 indicates that endogenous SH2B1 reg-
ulates the NGF induction of these three genes. To test
this more directly, we used an RNA interference (RNAi)
approach to stably reduce levels of endogenous
SH2B1 in PC12 cells. As shown in Fig. 9A, the level of
endogenous SH2B1 in cells stably expressing a 21-
nucleotide long shRNA duplex targeted against
SH2B1 (PC12-shSH2B1 cells) was reduced to less
than 50% the level in cells stably expressing the vector
only (shControl cells) when normalized to levels of
-tubulin. As predicted from the experiments using
PC12-SH2B1 and PC12-SH2B1(R555E) cells,
PC12-shSH2B1 cells exhibited substantially reduced
NGF-induced neurite outgrowth compared with con-
trol cells (Maures, T., L. Chen, and C. Carter-Su,
manuscript in preparation). In support of endogenous
SH2B1 enhancing NGF-induced expression of Plaur,
Mmp3, and Mmp10, PC12-shSH2B1 cells exhibited
substantially suppressed NGF-induced levels of ex-
pression of Plaur (by 56%), Mmp3 (by 47%), and
Mmp10 (by 76%) compared with control cells (Fig.
9B), levels of reduction consistent with the level of
reduction in SH2B1 protein. Levels of GAPDH gene
expression were not affected by NGF, nor were they
significantly different for the two cell lines, indicating
that the differences in NGF induction seen in Plaur,
Fig. 5. Physiological Functions of uPAR/MMP Activation
Cascade
Cell surface-localized uPAR, together with cathepsins,
binds to pro-uPA and converts inactive pro-uPA to active
uPA. The active uPA converts plasminogen to plasmin,
and the active plasmin cleaves and thereby activates
MMPs. Active MMP has been shown to regulate ECM
degradation.
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Mmp3, and Mmp10 expression in the different cell
lines were not due to nonspecific effects of the shRNAi
on gene transcription or cell viability.
DISCUSSION
Microarray Analysis Identifies Novel
NGF-Responsive Genes Likely to Be Important
for NGF-Induced Neuronal Differentiation
In this study, we applied genome-scale gene expres-
sion analysis to identify SH2B1-regulated genes and
to gain insight into whether the adaptor protein
SH2B1 enhances NGF-induced regulation of all
NGF-sensitive genes, as predicted if SH2B1 simply
potentiates NGF activation of TrkA, or whether it alters
expression of a subset of NGF-sensitive genes as
predicted if SH2B1 were acting downstream of TrkA.
Because we were interested in the early events of
NGF-induced neuronal differentiation, including neu-
rite outgrowth, we looked at the gene expression pro-
files of the well-defined sympathetic neuron model
PC12 cells before and after 6 h treatment of NGF.
Although our main goal was to identify genes that are
regulated by SH2B1, our microarray analysis also
Fig. 7. SH2B1 Enhances NGF-Induced MMP3/MMP10 Activity
A, Control PC12, PC12-SH2B1, or PC12-SH2B1(R555E) cells were treated with 100 ng/ml NGF for 0, 3, 6, 8, and 10 h. Proteins
in concentrated conditioned medium were separated in casein-containing, prestained zymogram gels and then developed for 16 h. A
representative gel is shown. B, TheMMP3/10 activity in A was quantified by band intensity using NIH Image software. C, NGF-induced
MMP3/10 activity was quantified for three independent experiments. Means	 SEM are shown. MMP3/10 activity levels of the three cell
lines are significantly different (P  0.05, one-tailed, paired Student’s t test) at 10 h, and by 8 h, MMP3/10 activity in PC12-SH2B1
cells was elevated above control cells (P  0.05).
Fig. 6. SH2B1 Enhances NGF-Induced uPAR Protein Expression but Does Not Affect the Subcellular Distribution of Cell
Surface-Localized uPAR
A, PC12 cells stably expressing GFP, GFP-SH2B1, or GFP-SH2B1(R555E) were incubated with 100 ng/ml NGF for 0, 4, and 6 h.
Proteins in a whole-cell lysate were separated by SDS-PAGE under nonreducing conditions, and uPAR protein levels were determined
by immunoblotting with antibody to rat uPAR. Expression levels of GFP-SH2B1, GFP-SH2B1(R555E), and actin were determined
under reducing conditions by immunoblotting proteins in whole-cell lysates with -GFP or -actin, respectively. The molecular weight
markers are noted on the left (n  2). B, PC12 cells stably expressing GFP, GFP-SH2B1, or GFP-SH2B1(R555E) plated on
Matrigel-coated coverslips were incubated with 100 ng/ml NGF for 0, 7, or 24 h as indicated and fixed with 4% paraformaldehyde but
not permeabilized before addition of monoclonal uPAR antibody and antimouse Alexa Fluor 555. Representative confocal images are
shown. The inset in I is an image of a different focal plane that focused more on the neurite. The experiment was repeated three times
with similar results.
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identified over 1000 genes whose expression was sub-
stantially regulated by NGF, many more than identified
previously. Several other studies have reported NGF-
induced gene expression on a large scale (42–49); how-
ever, most of these studies focused on the late response
genes induced by 4 or more days of NGF treatment. The
few studies looking at earlier time points identified a
limited number of NGF-sensitive genes, the majority of
which were also identified as NGF-sensitive genes in our
microarray analysis. For example, Chou et al. (50) used
gene expression profiling of PC12 cells at 1, 6, and 24 h
after NGF treatment to identify nine genes of 588 genes
and ESTs that were highly regulated (300 or 33% of
control) in response to NGF. Expression of the two genes
[Mmp10 and Vgf encoding VGF nerve growth factor in-
ducible/VGF8a protein/neurosecretory protein VGF pre-
cursor] found to be highly up-regulated after 6 h treat-
ment with NGF were also highly up-regulated (7- and
38-fold, respectively) by 6 h of NGF in our microarray
study. Among the NGF-regulated genes identified by
Brown et al. (49) using targeted display to identify NGF-
sensitive genes after 2, 4, and 6 h, our microarray data
showed similar up-regulation by NGF of Catna1 encod-
ing -catenin, Odc1 encoding ornithine decarboxylase,
Gsr encoding glutathione reductase, and Nup54 encod-
ing p54 nucleoporin and down-regulation of Gucy1b3
encoding -subunit of soluble guanylate cyclase and
Chaf1A encoding p150 chromatic assembly factor. Fi-
nally, our microarray also identified as highly NGF de-
pendent six genes identified by Herschman’s group (33,
Fig. 8. SH2B1 Enhances NGF-Induced Neurite Invasive-
ness of PC12 Cells
A, Schematic of transwell system used to measure neurite
invasiveness. Cells were added onto growth factor-reduced
Matrigel on the cis-plane of a transwell insert. Neurite invasive-
ness was assessed by counting the neurites appearing on the
trans-plane of the transwell insert. B, Control PC12 cells or
PC12-SH2B1 cells were added to theMatrigel on the cis-plane
of a transwell insert, and 100 ng/ml NGFwas added to the outer
chamber. After 4 d, the cells on the insert were fixed and
immunostained with anti--tubulin and Alexa Fluor 555. Neu-
rites that traversed to the trans-plane were counted. Means 	
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Fig. 9. The siRNA-Mediated Knockdown of Endogenous
SH2B1 Inhibits NGF-Dependent Induction of Plaur, Mmp3,
and Mmp10
A, Proteins in lysates of PC12 cells stably expressing the
control shRNA (shControl) or shRNA targeted against SH2B1
(shSH2B1) were separated by SDS-PAGE and immunoblotted
with -SH2B1 and then anti--tubulin as a loading control. B,
After incubation in serum-free medium overnight, PC12 cells
expressing control shRNA or shRNA targeted against SH2B1
were incubated with or without 50 ng/ml NGF for 6 h. The
NGF-dependent induction of mRNA for Plaur, Mmp3, and
Mmp10 was quantified via QT-PCR. Gene expression in the
presence of NGF was divided by expression in the absence of
NGF and then normalized to levels of GAPDH expression in the
presence of NGF divided by expression in the absence of NGF.
Results were then further normalized to those obtained using
shControl cells. Means 	 SEM are shown for n  3. *, P  0.05
using a one-tailed, paired Student’s t test; #, P  0.06.
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48, 51) as being induced by 1–4 h of NGF but not epi-
dermal growth factor (EGF) treatment using representa-
tional difference analysis: Arc (encoding activity-
regulated cytoskeletal protein), Mmp13 (encoding
MMP13/collagenase-3), Serpine1 (encoding plasmino-
gen activator inhibitor-1 precursor/PAI-1), VH6/MKP-3/
Dusp6 (encoding dual specificity phosphatase 6/MAPK
phosphatase 3), Plaur, and Nid67 (encoding NGF-
induced differentiation clone 67 protein).
In addition to these previously identified NGF-induced
genes, our microarray data identified close to 500 addi-
tional genes and ESTs whose expression was at least
doubled with 6 h of NGF treatment and close to 150
additional genes and ESTs whose expression was at
least tripled. More than 500 genes and ESTs showed an
NGF-induced decrease in expression of 50% or greater,
with over 100 showing a 66% or greater decrease. The
NGF-sensitive genes identified in our study that were
up-regulated at least 2-fold were overrepresented in the
gene ontology categories of morphogenesis, organo-
genesis, cell death, intracellular signaling, and cell differ-
entiation, consistent with NGF promoting differentiation
and survival of sensory and sympathetic neurons. Those
genes that were down-regulated at least 50% by NGF
were overrepresented in the categories of cell cycle,
proliferation, and migration, consistent with the known
decrease in cell proliferation and movement that occurs
during differentiation. Some of these NGF-regulated
genes [e.g. genes encoding integrin 1, lectin, galactose
binding, soluble 3 (45), bradykinin B2 receptor (46), and
Bip3 (52)] had been shown previously to be regulated by
NGF in PC12 cells using a variety of techniques, al-
though not always at such an early time point (6 h) after
NGF addition. Other genes (e.g. Glrx1 encoding glutare-
doxin 1, Ca2 encoding carbonic anhydrase-II, and Stc1
encoding stanniolcalcin 1) were revealed for the first time
to be highly responsive to NGF. Many of the proteins
encoded by our newly identified NGF-regulated genes,
including Glrx1, Stc1, and Ca2, had, however, been pre-
viously identified in neurons and, in some cases, been
implicated in neuronal differentiation and/or function. For
instance, glutaredoxin 1 is thought to play an important
role in maintaining nerve cell function in the presence of
oxidative stress, at least in part by catalyzing the removal
of glutathione fromS-glutathionylated proteins (reviewed
in Ref. 53). Because even small changes in the redox
state of a cell have been shown to switch cells from
proliferation to differentiation or vice versa (reviewed in
Ref. 54), our finding that NGF greatly up-regulates glu-
taredoxin 1 expression raises the possibility that glutare-
doxin 1 also plays an important role in NGF-induced
neuronal differentiation. Proteins that regulate cellular
pH, such as carbonic anhydrase II, are also thought to be
especially important in the nervous system because
electrical activity can elicit rapid changes in cellular pH
(55). Our finding that carbonic anhydrase II, found in
certain subsets of nerves, is rapidly and profoundly up-
regulated by NGF in differentiating PC12 cells, and the
finding of Dickens et al. (56) that tips of extending neu-
rites appear to be more alkaline (by 0.2–0.3 pH units)
than the cell body raise the possibility that carbonic
anhydrase II plays a specific role in neurite outgrowth.
Although not previously reported to be induced by NGF,
stanniolcalcin-1, a glycoprotein hormone implicated in
the regulation of calcium and phosphate homeostasis,
has been reported to be induced during differentiation of
a variety of cell types, including human neural crest-
derived Paju cells (stimulated by phorbol esters) (57) and
murine Neuro-2A neuroblastoma cells (stimulated by
dibutyryl cAMP) (58). Decreasing its expression in
Neuro-2A cells using antisense oligodeoxynucleotides
reduces in neurite outgrowths the level of varicoses, a
phenotypic marker of axon formation. This finding led to
the suggestion that stanniolcalcin-1, which is found in
neurons in human and adult mouse brain, is involved in
axonal formation. Clearly, knowledge and further explo-
ration of these proteins and the proteins encoded by the
large number of other genes newly found to be NGF
sensitive should greatly facilitate our understanding of
how NGF induces neuronal differentiation and promotes
neuronal survival.
SH2B1 Enhances the NGF Regulation of a
Subset of Genes Likely to Be Involved in
Neuronal Differentiation
Comparison of the gene expression profiles of control
cells and cells stably expressing SH2B1 or the dom-
inant-negative SH2B1(R555E) revealed a number of
NGF-induced and -depressed genes that are differen-
tially regulated by SH2B1 and SH2B1(R555E).
Some genes whose expression is substantially up-
regulated by SH2B1 have been reported previously
to be expressed in neurons but were not known to be
regulated by NGF [i.e. Stc1, Glrx1(a), and Scn6a] (59–
61). Other NGF-sensitive genes whose NGF stimula-
tion is increased by SH2B1 (e.g. Arc, Fosl1/Fra1,
Dusp6, Egr1, and Plaur) have been shown previously
to be regulated by NGF in neuronal cells (33, 48, 62).
The gene products of a few (i.e. Plaur and Gap-43/
Basp2) have even been implicated previously in NGF-
induced neurite outgrowth (33, 63). For the six genes
tested (Glrx1, Ca2, Stc1, Mmp3, Mmp10, and Plaur),
QT-PCR analysis confirmed both their up-regulation
by NGF and the ability of SH2B1 to increase the
magnitude of that up-regulation. QT-PCR analysis fur-
ther revealed that for all six of the genes tested,
SH2B1 significantly enhanced levels of expression at
multiple time points after NGF addition, indicating that
the SH2B1-stimulated levels of expression seen at
6 h of NGF treatment in the microarray were not simply
a consequence of a shift in the time course of NGF
activation. Western blotting, activity assays, and/or
immunocytochemistry indicated that increased ex-
pression of Plaur, Mmp3, and Mmp10 genes in PC12-
SH2B1 cells results in increased protein expression
of uPAR and MMP3/10 and that decreased gene ex-
pression of Plaur, Mmp3, and Mmp10 genes in PC12-
SH2B1B(R555E) cells results in decreased protein ex-
pression of uPAR and MMP3/10.
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It is important to note, however, that although the NGF
responsiveness of a number of NGF-sensitive geneswas
enhanced by overexpressing SH2B1, there were similar
numbers of NGF-sensitive genes whose expression was
not substantially altered by overexpressing SH2B1.
Genes in this latter category included some genes
whose expression is considered critical for NGF-induced
neuronal differentiation. For example, NGF-induced ex-
pression of Anxa2 encoding annexin II/calpactin 1 heavy
chain is thought to be critical for NGF-induced neuronal
differentiation of PC-12 cells. Polyclonal andmonoclonal
antibodies directed against annexin II and overexpres-
sion of antisense annexin II mRNA inhibit NGF-induced
PC12 neurite outgrowth on a plate and within a three-
dimensional matrix (64). Annexin II is reported to be a
coreceptor for plasminogen and tissue plasminogen ac-
tivator, which promotes and localizes plasmin generation
near the cell surface (65, 66). Although in our microarray,
NGF was observed to stimulate the expression of Anxa2
to three times the level seen in the absence of NGF, NGF
induction of expression was similar in control, PC12-
SH2B1, and PC12-SH2B1(R555E) cells. Like Plaur,
Vgf, encoding VGF nerve growth factor-inducible pro-
tein, is a primary response gene that is specific for NGF
and not EGF and peaks in expression in PC12 cells after
2–8 h of NGF (33). Ret encoding the common receptor
for glial cell line-derived neurotrophic factor (GDNF) fam-
ily ligands is thought to be required for GDNF to instruct
a subset of TrkA sensory neurons to adopt a nonpep-
tidergic sensory neuron fate (67). Although in control
cells we observed NGF to substantially increase expres-
sion of both Vgf and Ret (by 7-fold), the NGF-induced
expression of these two genes was not altered in PC12-
SH2B1 or PC12-SH2B1(R555E) cells. Taken together,
these findings suggest that SH2B1 enhances the ex-
pression of a critical subset of NGF-responsive genes
implicated in neuronal differentiation.
SH2B1 Enhances the Ability of Nerves to
Express uPAR and MMP3/10, Which in Turn
Enhances the Ability of Neurites to Invade the
Extracellular Matrix
When we looked at the top five genes whose NGF-
induced expression at 6 h by microarray analysis was
most highly up-regulated in PC12-SH2B1 cells or
down-regulated in PC12-SH2B1(R555E) cells com-
pared with control cells, we were impressed by the
fact that three of the protein products (uPAR, MMP3,
and MMP10) are involved in the same pathway of ECM
degradation, a pathway critical for neurite outgrowth.
What was even more striking is that the genes encod-
ing these three proteins were also among the top 12
genes up-regulated by NGF at 6 h in control cells. One
of these genes (Plaur) is a known early-response gene
regulated by NGF (which promotes neuronal differen-
tiation of PC12 cells) but not EGF (which does not
promote neuronal differentiation of PC12 cells), shown
previously to be essential for NGF-induced neurite
outgrowth and biochemical differentiation (33, 34).
These combined observations caused us to focus on
uPAR, MMP3, and MMP10 as key mediators of the
stimulatory effect of SH2B1 on NGF-induced neurite
outgrowth.
The key features of NGF-dependent neuronal growth,
such as the initiation and extension of the axon, are
contingent upon the formation and motility of the growth
cones. uPAR and MMP3 and -10 function together in a
pathway to modulate the cell’s degradation of the sur-
rounding ECM, allowing the axon to invade or penetrate
the ECM. uPAR is a glycosylphosphatidylinositol-linked
protein that binds to and activates urokinase plasmino-
gen activator (uPA) at the cell surface. uPAR has been
implicated as being vital for NGF-induced differentiation
of PC12 cells. Thus, in PC12 cells, anti-uPAR antibody to
the extracellular domain of uPAR and antisense RNA
targeted to uPAR message both block NGF-induced
neurite outgrowth and appearance of biochemical mark-
ers of neuronal differentiation (34). uPAR is also thought
to be an essential player for neuronal differentiation in
vivo. uPAR is found in primary neurons and has been
implicated in the differentiation of primary neurons. Hay-
den and Seeds (68) report that uPAR mRNA levels
greatly increase during differentiation of cultured cells
from mouse dorsal root ganglia. The time course of the
transient increase (maximum at 30 h) directly correlated
with the differentiation of neurons and the formation of a
neuritic network in the regenerating cultures. Levels of
uPAR mRNA also increase in sensory neurons after sci-
atic nerve crush in adult mice (69), and the neocortex of
uPAR/ adult mice has fewer GABAergic interneurons
during embryonic and postnatal periods (70, 71).
Activated uPA converts plasminogen to plasmin,
which subsequently cleaves inactive MMPs into active
extracellular proteases. There are currently 28 identified
enzymes in the MMP family, each displaying a propen-
sity for the cleavage of specific substrates. MMP3 and
-10 are secreted proteinases that are cleaved by plas-
min; they are both capable of degrading a broad spec-
trum of substrates, including collagen I, III, IV, and V and
fibronectin (32). In response to signals like NGF, neurons
position these ECM proteases to their growth cones. In
PC12 cells, the time course of NGF-induced Mmp3 ex-
pression is largely coincident with neuronal differentia-
tion (72), andMMP3 has been implicated in themotility of
the growth cone (36, 73). Knocking downMMP3 in PC12
cells blocks NGF-induced neurite invasion or extension
through Matrigel, suggesting that MMP3 is vital for axon
outgrowth through the ECM. In support of a role of
MMPs in axonal outgrowth in vivo, MMP3 and MMP10
are found in primary neurons. MMPs have also been
implicated in penetration of dorsal root ganglion neurites
through the ECM (74). Thus, in the most simplistic ex-
planation of how uPAR, MMP3, and MMP10 mediate
neurite outgrowth, NGF causes an increased transcrip-
tion/translation of uPAR and MMPs, bestowing the cell
with a greater proteolytic potential that allows the growth
cones to cut through the ECM, clearing a pathway for the
neurite. The ability of SH2B1 to greatly increase the
expression of uPAR and increase and prolong the ex-
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pression of both MMP3 and MMP10 suggests that
SH2B1 is required for the degradation of the ECM
required for axonal outgrowth of NGF-sensitive nerves.
This is supported by our finding that both overexpression
of the dominant-negative SH2B1(R555E) and reduction
of expression of endogenous SH2B1 using shRNA to
SH2B1 substantially decrease the expression of uPAR,
MMP3, andMMP10. It is further supported by the finding
that cells overexpressing SH2B1 both increased the
amount of enzymatically active MMP3/10 over levels
associated with control PC12 cells in response to NGF
as well as NGF-induced neurite invasion through
Matrigel.
However, the contribution of uPAR and MMPs, and
thus SH2B1, to neurite outgrowth may extend beyond
this simple explanation. The requirement for functional
uPAR during NGF-dependent differentiation of PC12
cells is transient and essential only for the initial hours of
NGF exposure (33, 34). Furthermore, not only does de-
pletion or inhibition of plasma membrane uPAR block
NGF-induced neurite outgrowth in a culture plate, but it
also blocks biochemical differentiation assessed as ex-
pression of COX-1 and type II sodium channel and ex-
pression of bothMMP3 (transin) andMMP1 (collegenase
I) (33). These observations suggest that uPAR is an im-
mediate-early gene product of NGF whose function may
be required for induction of a wave of secondary re-
sponse genes important for differentiation. Indeed, uPAR
has also been reported in other cell types to activate a
variety of intracellular signaling pathways and increase
levels of a variety of signaling molecules. The pathways
and molecules include Janus kinase 1/signal transducer
and activator of transcription 1 (75), MEK/ERK (76), the
Src family kinase hck (77), and protein kinase C (78)
pathways as well as diacylglycerol (79, 80), cAMP (81),
calcium released from internal stores (82), and inositol
phosphate turnover (83). In other cell model systems,
uPAR has been reported to form stable complexes with
integrins that alter the adhesive properties of the cells
(84, 85). Thus, NGF-induced neuronal differentiation and
enhancement of that differentiation by SH2B1may also
require uPAR activation of cellular signaling pathways.
In a similar vein, both axons and growth cones appear
to require MMPs to not only extend into the ECM but
also to remove inhibitor proteins and process guidance
cues (reviewed in Ref. 86). MMP3 has been implicated in
synaptogenesis (87) and found to confer neuronal sur-
vival properties by removing Fas ligand from the neuro-
nal surface, thereby protecting against Fas-induced ap-
optosis (88). Thus, in intact neurons, as a consequence
of promoting and prolonging the NGF-induced expres-
sion of Mmp3 and Mmp10, SH2B1 may not only be
enhancing neurite invasion of the ECM, it may also be
enhancing neuronal survival and affecting synaptogen-
esis. A specific role for SH2B1 in neuronal survival is
consistent with the finding of Qian et al. (20) that anti-
bodies to SH2B1 introduced into dissociated sympa-
thetic neurons maintained in the presence of NGF pro-
mote cell death and that introduction of a dominant-
negative form of SH2B1 into explants of sympathetic
ganglia maintained in the presence of NGF result in ax-
onal degeneration.
Cellular Mechanism by which SH2B1 Enhances
Expression of uPAR and MMP3
Mmp3 expression has been shown to be dependent
upon uPAR expression (33, 48), making it likely that
SH2B1 enhancement of MMP3 expression is sec-
ondary to SH2B1 enhancement of uPAR expression.
The molecular mechanism by which SH2B1 en-
hances NGF-induced Plaur gene expression is un-
known. As discussed previously, one hypothesis is
that SH2B1 increases NGF induction of TrkA (29),
which would be expected to result in an increase in all
cellular responses to NGF, including expression of
Plaur. However, our data showing that SH2B1 in-
creases expression of only a subset of NGF-induced
genes and previous data showing that NGF induction
of TrkA is not enhanced in PC12-SH2B1(R555E) cells
(21, 30) argue against this being the primary explana-
tion for how SH2B1 stimulates expression of Plaur.
Recent findings suggest that NGF causes the recruit-
ment of c-Fos and JunB to an AP-1 regulatory element
within the uPAR promoter (89), raising the possibility
that SH2B1 somehow facilitates that process either
directly in its role as an adapter protein or indirectly by
promoting expression of c-Fos or JunB.
The work of Qian and colleagues (20, 29) is con-
sistent with SH2B1 enhancing NGF activation of
ERKs 1 and 2, which would be expected to increase
the expression of c-Fos. Arguing against this hy-
pothesis, however, is that although overexpression
of SH2B1 has a modest enhancing effect on NGF
activation of phosphorylation of ERKs 1 and 2 (21,
30), neither overexpression of SH2B1(R555E) (21)
nor reduction of endogenous SH2B1 (Maures, T., L.
Chen, and C. Carter-Su, manuscript in preparation)
inhibits NGF-induced ERK phosphorylation. In sup-
port of the conclusion that SH2B1 does not en-
hance NGF-induced Plaur expression and neuronal
differentiation solely by enhancing NGF-induced ac-
tivation of TrkA or ERKs 1 and 2, GDNF-induced
neuronal differentiation of PC12 cells stably over-
expressing GDNF receptor 1 and RET is also
enhanced by overexpression of SH2B1 but sup-
pressed by overexpression of SH2B1(R555E)
and by reduction of endogenous SH2B1 using
shRNA to SH2B1 (90). However, GDNF stimulation
of phosphorylation of ERKs 1 and 2 and Akt was not
appreciably suppressed by overexpression of
SH2B1(R555E).
Taken together, these findings suggest that SH2B1
enhances both NGF- and GDNF-induced neuronal dif-
ferentiation at a point downstream of or parallel to
ERKs. The additional findings that SH2B1 enhance-
ment of NGF-induced Plaur expression and neurite
outgrowth appear to require nuclear cytoplasmic shut-
tling of SH2B1 (30) (Maures, T., L. Chen, and C.
Carter-Su, manuscript in preparation) open up the
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possibility of a novel pathway that requires SH2B1 to
cycle through the nucleus.
Conclusion
In conclusion, our microarray analysis of PC12 cells
treated with or without NGF for 6 h identified about
1000 genes and ESTS whose expression was in-
creased or decreased by NGF by a factor of 2 or
more, many of which were not previously recognized
as being NGF-responsive genes. NGF-induced reg-
ulation of a substantial subset of these genes was
enhanced by overexpressing wild-type SH2B1
and/or suppressed by overexpressing dominant-
negative SH2B1(R555E). Another subset of NGF-
sensitive genes implicated previously in NGF induc-
tion of neuronal differentiation were unaffected by
overexpression of SH2B1 or SH2B1(R555E), sug-
gesting that SH2B1 acts primarily downstream of
TrkA. Three of the up-regulated genes (Plaur, Mmp3,
and Mmp10) were noted to be particularly sensitive
to both NGF and SH2B1. Their regulation by both
NGF and SH2B1 at the gene level was confirmed
by QT-PCR and at the protein level by immunoblot-
ting, immunocytochemistry, and/or functional as-
says. The protein products of these three genes lie
in the same functional pathway of ECM degradation
critical for neurite outgrowth; uPAR has been shown
previously to be critical for NGF-induced neuronal
differentiation and MMP3 for NGF-induced neurite
growth through a three-dimensional matrix. These
observations suggest that uPAR, MMP3, and
MMP10 are likely to play a critical role in the ability
of SH2B1 to facilitate NGF-induced neuronal differ-
entiation and neurite outgrowth. A critical role is
further suggested by our findings that depletion of
endogenous SH2B1 suppresses the ability of NGF
to enhance expression of all three genes and that
overexpression of SH2B1 promotes neurite extension
through a three-dimensional matrix. The additional find-
ing that nuclear cytoplasmic shuttling of SH2B1 is re-
quired for SH2B1 to promote NGF-dependent neuronal
differentiation makes it intriguing to speculate that nu-
clear SH2B1 directly facilitates expression of a subset
(e.g. Plaur) of NGF-sensitive genes.
MATERIALS AND METHODS
Antibodies and Reagents
Polyclonal antibody to rat SH2B1 (SH2B1), kind gift of Dr.
Liangyou Rui (University of Michigan), was raised against an
SH2B1 glutathione S-transferase fusion protein (91) and
used at a dilution of 1:1000 for Western blotting. Monoclonal
antibody to neuronal -tubulin (TUJ1) was from Covance
(Richmond, CA) (MMS-435P) and used at a dilution of 1:1000
for immunostaining of neurites. Antibody to -tubulin (Cell
Signaling Technology, Beverly, MA) was used at a dilution of
1:1000 for Western blotting. Polyclonal anti-MMP3 antibody
(MMP3) was from Chemicon (Temecula, CA; catalog no.
AB19150) and used at 1:1000 for Western blotting. A poly-
clonal antibody against the ligand-binding NH2-terminal do-
main of rat uPAR was used for Western blots at a dilution
1:500 as previously described (92). Antimouse uPAR mono-
clonal antibody used for immunostaining (at a dilution of
1:1000) was from R&D Systems (Minneapolis, MN; catalog
no. AF534). Alexa Fluor 555-conjugated anti-mouse IgG used
for immunocytochemistry and Alexa Fluor 680-conjugated
anti-rabbit IgG used for Western blotting came from Invitro-
gen (Carlsbad, CA). NGF, rat-tail collagen I, and growth fac-
tor-reduced Matrigel were purchased from BD Bioscience,
San Diego, CA. Purified human MMP3 was from Triple Points
Biologics (Forest Grove, OR; catalog no. H-MMP-3, 0.1 	g/
	l), fluorescein was from Bio-Rad (Hercules, CA) and SYBR
Green I was from Sigma Chemical Co. (St. Louis, MO). Taq-
Man RT-PCR kit was purchased from Applied Biosystems
(Roche, Indianapolis, IN) (catalog no. N808-0234).
Stable Cell Lines and Cell Culture
The stock of PC12 cells was purchased from American Type
Culture Collection (Rockville, MD). PC12 cells were plated on
collagen-coated plates (0.1 mg/ml rat tail collagen in 0.02 N
acetic acid) and grown at 37 C in 10% CO2 in DMEM (In-
vitrogen) supplemented with 10% heat-inactivated horse se-
rum (ICN, Aurora, OH), 5% fetal bovine serum (Invitrogen), 1
mM L-glutamine and 1 mM antibiotic-antimycotic (Invitrogen).
PC12 cells stably overexpressing GFP (control PC12 cells),
GFP-SH2B1 (PC12-SH2B1 cells), or GFP-SH2B1(R555E)
[PC12-SH2B1(R555E) cells] were described previously (30).
Experimental plates were incubated in serum-free medium
overnight and then treated with vehicle or 100 ng/ml NGF for
the indicated times.
RNA Preparation and Microarray Analysis
Total RNA was isolated from control and NGF-treated cells
using Stat60 (Tel-Test, Inc., Friendswood, TX) and RNeasy
spin columns (QIAGEN, Valencia, CA) according to the man-
ufacturers’ instructions. RNA from five experiments, each
performed in duplicate, was prepared and the quality of RNA
checked by OD and agarose gels. To assess further the
quality of the RNA and confirm that the cells responded to
NGF, QT-PCR was used to monitor the expression level of
some known NGF-responsive genes. Based on these results,
RNA from duplicates of two independent experiments was
combined in equal proportions for microarray analysis. In-
creasingly, data sets in the Gene Expression Omnibus Data-
base use pooled RNA samples for microarray analyses; the
advantage of pooled RNA samples has been documented
(93, 94). Preparation of cRNA from equal amounts of pooled
RNA per cell line and its hybridization to rat genome
RAE233A oligonucleotide arrays (Affymetrix, Santa Clara, CA)
was performed by the Cell and Molecular Biology Core of the
Michigan Diabetes Research and Training Center. The aver-
aged NGF responsiveness (NGF/NGF) was used in Ta-
bles 1, 2, and 4 for genes represented by more than one
probe set. Probe sets with raw data less than 100 in all six
samples were not included in Tables 1–4 to minimize false-
positive results. For calculating NGF responsiveness, values
of raw data that are smaller than 50 are regarded as 50.
QT-PCR
Gene expression of Plaur, Mmp3, Mmp10, Stc1, Ca2, and
Glrx1 was determined by QT-PCR using SYBR Green I and
the iCycler system with iCycler iQ Real Time Detection Sys-
tem software (Bio-Rad). Primer sequences were designed
using PrimerExpress software and are listed in Table 5. Am-
plicons generated from each primer pair were 50–52 bp.
Loading of each sample was normalized with fluorescein. All
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readings were normalized to the gene expression of glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH). Levels of
GAPDH expression were not different in control PC12, PC12-
SH2B1, and PC12-SH2B1(R555E) cells (Figs. 3 and 4) or in
shControl vs. PC12-shSH2B cells (Fig. 9B).
Cell Lysis and Immunoblotting
Cells were washed three times with chilled PBS [10 mM
sodium phosphate, 137 mM NaCl, (pH 7.4)] containing 1 mM
Na3VO4, solubilized in sample buffer [62.5 mM Tris-HCl (pH
6.8), 25% glycerol, 4% SDS, 0.01% bromophenol blue], and
boiled for 10 min before centrifugation at 13,200 rpm for 1
min. Equal amounts of the solubilized proteins were sepa-
rated on SDS-PAGE gels, transferred to polyvinylidene fluo-
ride (Fig. 6A) or nitrocellulose (Fig. 9A) membranes, immuno-
blotted with the indicated antibody, and detected using Alexa
Fluor 680-conjugated antirabbit IgG and an Odyssey Infrared
Imaging System (LI-COR Biosciences, Lincoln, NE).
Analysis of uPAR Distribution
PC12 cells were plated onto Matrigel-coated coverslips, de-
prived of serum and incubated for the indicated time with 100
ng/ml NGF. Cells were fixed with 4% paraformaldehyde and
incubated with uPAR monoclonal antibody followed by Alexa
Fluor 555-conjugated secondary antibody. Analysis of uPAR
distribution was performed with an Olympus FluoView 500
laser scanning confocal microscope using a 
60 oil-immer-
sion objective and FluoView version 5.0 software. Alexa Fluor
555 fluorescence was excited with a green HeNe laser at 543
nm, and emission was measured through a 560-nm long pass
filter (560 and above). GFP fluorescence was excited with an
Ar laser at 488 nm, and emission was measured through a
505- to 525-nm filter.
Zymogram Gel Analysis
PC12 cells were incubated overnight in DMEM containing
0.1% chicken ovalbumin and then treated with 100 ng/ml
NGF as indicated. Proteins in conditioned medium were con-
centrated 3- to 4-fold using Centricon 30 concentrator (Mil-
lipore, Bedford, MA) and separated on a 0.1% casein-con-
taining, prestained, Tris-glycine gel (Invitrogen) under
nonreducing conditions. The gel was washed three times
with renaturation buffer (2.5% Triton X-100) to remove SDS
and renature the MMPs and then developed overnight at 37
C in developing buffer [50 mM Tris-HCl (pH 7.5), 200 mM
NaCl, 5 mM CaCl2, 0.02% Brij-35] to visualize regions in the
gel that contain active MMP.
Neurite Outgrowth through Matrigel
Neurite outgrowth through Matrigel was assessed using a
modified method of Nordstrom et al. (36). Briefly, 50 	l of 1:3
diluted growth factor-reduced, phenol red-free Matrigel (BD
Biosciences) was added to the cis-plane of a 24-well trans-
well membrane (6.5 mm2, 5 	m pore size) and allowed to
solidify at 37 C for 30 min. The trans-plane of the transwell
membrane was coated with 1:10 diluted growth factor-re-
duced Matrigel overnight at room temperature. Cells were
plated onto the cis-plane of the transwell membrane at a
density of 50,000 cells per well in phenol red-free DMEM
containing 0.1% chicken ovalbumin. NGF (100 ng/ml) was
added to the outer chamber. After 4 d, cells were fixed and
immunostained for neuronal -tubulin (TUJ1) followed by
Alexa Fluor 555-conjugated secondary antibody. Neurites on
the trans-plane of the membrane were visualized by fluores-
cence microscopy (Nikon Eclipse TE2000) and counted.
Silencing of SH2B1 Gene
SH2B1 small interfering RNA (siRNA) vector was constructed
by inserting an oligonucleotide containing the SH2B1 se-
quence (5-CATCTGTGGTTCCAGTCCA-3) corresponding
to nucleotides 1771–1789 of rat SH2B1 (GenBank accession
no. AF047577) into the pSuper retro vector containing the
puromycin resistance gene (pSuper retro puro) (OligoEngine,
Seattle, WA). A pSuper vector containing a nontargeting
siRNA with a low sequence similarity to known genes was
used as a control. The SH2B1 and control siRNA vectors
were transfected into subconfluent PC12 cells using a Bio-
Rad Gene Pulser Xcell electroporator (400V, 500 	F, 0.4-cm
cuvette). After 14 h, cells were washed with PBS, and fresh
growth medium was added. Twenty-four hours later, the
medium was changed to a selection medium containing 5
	g/ml puromycin and selected for pSuper-positive PC12
cells for 30 d. The efficacy of the SH2B1 RNAi was assessed
using QT-PCR on RNA from the puromycin-resistant PC12
lines (data not shown).
Acknowledgments
We thank Dr. Richard Mortenson for the use of his iCycler
and help with QT-PCR and Dr. Stephen Lentz for his advice
on confocal imaging. We also thank Drs. Ronald Koenig and
Rork Kuick for their suggestions on microarray analysis and
Dr. Liangyou Rui for his generous gift of SH2B1 antibody.
We appreciate the advice of Dr. Lawrence S. Argetsinger on
zymogram analysis and this manuscript and the help of Ms.
Barbara Hawkins with this manuscript.
Received August 8, 2007. Accepted October 11, 2007.
Address all correspondence and requests for reprints to: Dr.
Christin Carter-Su, Department of Molecular and Integrative Phys-
iology, The University of Michigan Medical School, Ann Arbor,
Michigan 48109-0622. E-mail: cartersu@umich.edu.
Current address for L.C.: Institute of Molecular Medicine,
National Tsing Hua University, Hsinchu, Taiwan.
























Chen et al. • Analysis of Genes Sensitive to NGF and SH2B1 Mol Endocrinol, February 2008, 22(2):454–476 473
22, 2008 
 at Case Western Reserve Univ Cleveland Health Science Lib on Februarymend.endojournals.orgDownloaded from 
This work was supported by National Institutes of Health
(NIH) Grant RO1-DK54222. Affymetrix microarray analysis was
performed by the Cell and Molecular Biology Core of the Mich-
igan Diabetes Research and Training Center (NIH5P60
DK20572 from the National Institute of Diabetes and Digestive
and Kidney Diseases). This work also used the Morphology and
Image Analysis Core of the Michigan Diabetes Research and
Training Center. T.J.M. was supported by the Cellular and Mo-
lecular Biology Predoctoral Training Grant (NIH Grant T32-
GM07315), a Cancer Biology Predoctoral Fellowship from the
University of Michigan, and a Rackham Predoctoral Fellowship
from the University of Michigan. H.J. was supported by The
Program in Pediatric Endocrinology and Diabetes Postdoctoral
Training Grant (NIH Grant T32-DK071212). J.S.H. was sup-
ported by the Cellular and Molecular Biology Predoctoral Train-
ing Grant (NIH Grant T32-GM07315), a National Defense Sci-
ence and Engineering Graduate Predoctoral Fellowship from
the U.S. Department of Defense, and a National Science Foun-
dation Graduate Fellowship.
The unprocessed microarray data are accessible through GEO
series accession no. GSE4557 in the NCBI Gene Expression Om-
nibus (GEO, http://www.ncbi.nlm.nih.gov/geo).
Disclosure Statement: The authors have nothing to disclose.
REFERENCES
1. Thoenen H, Barde YA 1980 Physiology of nerve growth
factor. Physiol Rev 60:1284–1335
2. Levi-Montalcini R 1987 The nerve growth factor 35 years
later. Science 237:1154–1162
3. Oppenheim RW 1991 Cell death during development of the
nervous system. Annu Rev Neurosci 14:453–501
4. Sofroniew MV, Howe CL, Mobley WC 2001 Nerve growth
factor signaling, neuroprotection, and neural repair. Annu
Rev Neurosci 24:1217–1281
5. Francis NJ, Landis SC 1999 Cellular and molecular deter-
minants of sympathetic neuron development. Annu Rev
Neurosci 22:541–566
6. Oltvai ZN, Milliman CL, Korsmeyer SJ 1993 Bcl-2 het-
erodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell 74:609–619
7. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-
Meek S, Armanini MP, Ling LH,MacMahon SB, Shelton DL,
Levinson AD 1994 Mice lacking nerve growth factor display
perinatal loss of sensory and sympathetic neurons yet de-
velop basal forebrain cholinergic neurons. Cell 76:
1001–1011
8. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin
A, Lira SA, Barbacid M 1994 Severe sensory and sympa-
thetic neuropathies in mice carrying a disrupted Trk/NGF
receptor gene. Nature 368:246–249
9. Patel TD, Jackman A, Rice FL, Kucera J, Snider WD 2000
Development of sensory neurons in the absence of NGF/
TrkA signaling in vivo. Neuron 25:345–357
10. Glebova NO, Ginty DD 2004 Heterogeneous requirement of
NGF for sympathetic target innervation in vivo. J Neurosci
24:743–751
11. Kuruvilla R, Zweifel LS, Glebova NO, Lonze BE, Valdez G,
Ye H, Ginty DD 2004 A neurotrophin signaling cascade
coordinates sympathetic neuron development through dif-
ferential control of TrkA trafficking and retrograde signaling.
Cell 118:243–255
12. Greene LA, Tischler AS 1976 Establishment of a noradren-
ergic clonal line of rat adrenal pheochromocytoma cells
which respond to nerve growth factor. Proc Natl Acad Sci
USA 73:2424–2428
13. Tischler AS, Greene LA 1980 Phenotypic plasticity of pheo-
chromocytoma and normal adrenal medullary cells. Adv
Biochem Psychopharmacol 25:61–68
14. Zhou T, Xu B, Que H, Lin Q, Lv S, Liu S 2006 Neurons
derived from PC12 cells have the potential to develop syn-
apses with primary neurons from rat cortex. Acta Neurobiol
Exp (Wars) 66:105–112
15. Vaudry D, Stork PJ, Lazarovici P, Eiden LE 2002 Signaling
pathways for PC12 cell differentiation: making the right
connections. Science 296:1648–1649
16. Schlessinger J, Ullrich A 1992 Growth factor signaling by
receptor tyrosine kinases. Neuron 9:383–391
17. Choi DY, Toledo-Aral JJ, Segal R, Halegoua S 2001 Sus-
tained signaling by phospholipase C- mediates nerve
growth factor-triggered gene expression. Mol Cell Biol 21:
2695–2705
18. Huang EJ, Reichardt LF 2003 Trk receptors: roles in neu-
ronal signal transduction. Annu Rev Biochem 72:609–642
19. Meakin SO 2000 Nerve growth factor receptors and mech-
anisms of intracellular signal transduction. Recent Res Dev
Neurochem 3:75–91
20. Qian X, Riccio A, Zhang Y, Ginty DD 1998 Identification and
characterization of novel substrates of Trk receptors in de-
veloping neurons. Neuron 21:1017–1029
21. Rui L, Herrington J, Carter-Su C 1999 SH2-B is required for
nerve growth factor-induced neuronal differentiation. J Biol
Chem 274:10590–10594
22. Rui L, Herrington J, Carter-Su C 1999 SH2-B, amembrane-
associated adapter, is phosphorylated on multiple serines/
threonines in response to nerve growth factor by kinases
within the MEK/ERK cascade. J Biol Chem 274:
26485–26492
23. Osborne MA, Dalton S, Kochan JP 1995 The yeast tribrid
system: genetic detection of trans-phosphorylated ITAM-
SH2-interactions. Biotechnology 13:1474–1478
24. Yokouchi M, Suzuki R, Masuhara M, Komiya S, Inoue A,
Yoshimura A 1997 Cloning and characterization of APS, an
adaptor molecule containing PH and SH2 domains that is
tyrosine phosphorylated upon B-cell receptor stimulation.
Oncogene 15:7–15
25. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI 1995
Cloning and characterization of Lnk, a signal transduction
protein that links T-cell receptor activation signal to phos-
pholipase C1, Grb2, and phosphatidylinositol 3-kinase.
Proc Natl Acad Sci USA 92:11618–11622
26. Maures TJ, Kurzer JH, Carter-Su C 2007 SH2B1 (SH2-B)
and JAK2: a multifunctional adaptor protein and kinase
made for each other. Trends Endocrinol Metab 18:38–45
27. Nelms K, O’Neill TJ, Li S, Hubbard SR, Gustafson TA, Paul
WE 1999 Alternative splicing, gene localization, and binding
of SH2-B to the insulin receptor kinase domain. Mammalian
Genome 10:1160–1167
28. Yousaf N, Deng Y, Kang Y, Riedel H 2001 Four PSM/SH2-B
alternative splice variants and their differential roles in mi-
togenesis. J Biol Chem 276:40940–40948
29. Qian X, Ginty DD 2001 SH2-B and APS are multimeric
adapters that augment TrkA signaling. Mol Cell Biol 21:
1613–1620
30. Chen L, Carter-Su C 2004 Adapter protein SH2-B under-
goes nucleocytoplasmic shuttling: implications for nerve
growth factor induction of neuronal differentiation. Mol Cell
Biol 24:3633–3647
31. Dennis Jr. G, Sherman BT, Hosack DA, Yang J, Gao W,
Lane HC, Lempicki RA 2003 DAVID: Database for annota-
tion, visualization, and integrated discovery. Genome Biol
4:P3
32. Sternlicht MD,Werb Z 2001 Howmatrix metalloproteinases
regulate cell behavior. Annu Rev Cell Dev Biol 17:463–516
33. Farias-Eisner R, Vician L, Silver A, Reddy S, Rabbani SA,
Herschman HR 2000 The urokinase plasminogen activator
receptor (UPAR) is preferentially induced by nerve growth
factor in PC12 pheochromocytoma cells and is required for
NGF-driven differentiation. J Neurosci 20:230–239
34. Farias-Eisner R, Vician L, Reddy S, Basconcillo R, Rabbani
SA,WuYY, BradshawRA, HerschmanHR2001 Expression
of the urokinase plasminogen activator receptor is tran-
siently required during “priming” of PC12 cells in nerve
474 Mol Endocrinol, February 2008, 22(2):454–476 Chen et al. • Analysis of Genes Sensitive to NGF and SH2B1
22, 2008 
 at Case Western Reserve Univ Cleveland Health Science Lib on Februarymend.endojournals.orgDownloaded from 
growth factor-directed cellular differentiation. J Neurosci
Res 63:341–346
35. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K,
Kondo T 2003 Glutaredoxin exerts an antiapoptotic effect
by regulating the redox state of Akt. J Biol Chem 278:
50226–50233
36. Nordstrom LA, Lochner J, Yeung W, Ciment G 1995 The
metalloproteinase stromelysin-1 (transin) mediates PC12
cell growth cone invasiveness through basal laminae. Mol
Cell Neurosci 6:56–68
37. Popanda O, Flohr C, Dai JC, Hunzicker A, Thielmann HW
2001 A mutation in subunit B of the DNA polymerase -pri-
mase complex from Novikoff hepatoma cells concomitant
with a conformational change and abnormal catalytic prop-
erties of the DNA polymerase -primase complex. Mol Car-
cinog 31:171–183
38. Basbaum CB, Werb Z 1996 Focalized proteolysis: spatial
and temporal regulation of extracellular matrix degradation
at the cell surface. Curr Opin Cell Biol 8:731–738
39. Ossowski L, Aguirre-Ghiso JA 2000Urokinase receptor and
integrin partnership: coordination of signaling for cell adhe-
sion, migration and growth. Curr Opin Cell Biol 12:613–620
40. Powell K 2003 Signalling: from the outside in. In: Signalling
scissors: new perspectives on proteases. Palazzo Arzaga,
Italy: Nature Publishing Group; 1–3
41. Galazka G,Windsor LJ, Birkedal-Hansen H, Engler JA 1996
APMA (4-aminophenylmercuric acetate) activation of
stromelysin-1 involves protein interactions in addition to
those with cysteine-75 in the propeptide. Biochem 35:
11221–11227
42. Angelastro JM, Klimaschewski L, Tang S, Vitolo OV,Weiss-
man TA, Donlin LT, Shelanski ML, Greene LA 2000 Identi-
fication of diverse nerve growth factor-regulated genes by
serial analysis of gene expression (SAGE) profiling. Proc
Natl Acad Sci USA 97:10424–10429
43. Oe T, Sasayama T, Nagashima T, Muramoto M, Yamazaki
T, Morikawa N, Okitsu O, Nishimura S, Aoki T, Katayama Y,
Kita Y 2005 Differences in gene expression profile among
SH-SY5Y neuroblastoma subclones with different neurite
outgrowth responses to nerve growth factor. J Neurochem
94:1264–1276
44. Zhu Y, Lee HC, Zhang L 2002 An examination of heme
action in gene expression: heme and heme deficiency af-
fect the expression of diverse genes in erythroid k562 and
neuronal PC12 cells. DNA Cell Biol 21:333–346
45. Lee KH, Ryu CJ, Hong HJ, Kim J, Lee EH 2005 CDNA
microarray analysis of nerve growth factor-regulated gene
expression profile in rat PC12 cells. Neurochem Res 30:
533–540
46. Marek L, Levresse V, Amura C, Zentrich E, Van Putten V,
Nemenoff RA, Heasley LE 2004 Multiple signaling conduits
regulate global differentiation-specific gene expression in
PC12 cells. J Cell Physiol 201:459–469
47. Lee NH, Weinstock KG, Kirkness EF, Earle-Hughes JA,
Fuldner RA, Marmaros S, Glodek A, Gocayne JD, Adams
MD, Kerlavage AR, Fraser CM, Venter JC 1995 Compara-
tive expressed-sequence-tag analysis of differential gene
expression profiles in PC-12 cells before and after nerve
growth factor treatment. Proc Natl Acad Sci USA 92:
8303–8307
48. Vician L, Basconcillo R, Herschman HR 1997 Identification
of genes preferentially induced by nerve growth factor ver-
sus epidermal growth factor in PC12 pheochromocytoma
cells by means of representational difference analysis.
J Neurosci Res 50:32–43
49. Brown AJ, Hutchings C, Burke JF, Mayne LV 1999 Appli-
cation of a rapid method (targeted display) for the identifi-
cation of differentially expressed mRNAs following NGF-
induced neuronal differentiation in PC12 cells. Mol Cell
Neurosci 13:119–130
50. Chou TT, Trojanowski JQ, Lee VM 2001 p38 mitogen-
activated protein kinase-independent induction of gadd45
expression in nerve growth factor-induced apoptosis inme-
dulloblastomas. J Biol Chem 276:41120–41127
51. Vician L, Silver AL, Farias-Eisner R, Herschman HR 2001
NID67, a small putative membrane protein, is preferentially
induced by NGF in PC12 pheochromocytoma cells. J Neu-
rosci Res 64:108–120
52. Imaizumi K, Tsuda M, Imai Y, Wanaka A, Takagi T, To-
hyama M 1997 Molecular cloning of a novel polypeptide,
DP5, induced during programmed neuronal death. J Biol
Chem 272:18842–18848
53. Maher P 2006 Redox control of neural function: back-
ground, mechanisms, and significance. Antioxid Redox
Signal 8:1941–1970
54. Noble M, Mayer-Proschel M, Proschel C 2005 Redox reg-
ulation of precursor cell function: insights and paradoxes.
Antioxid Redox Signal 7:1456–1467
55. Chesler M 2003 Regulation and modulation of pH in the
brain. Physiol Rev 83:1183–1221
56. Dickens CJ, Gillespie JI, Greenwell JR 1989 Interactions
between intracellular pH and calcium in single mouse neu-
roblastoma (N2A) and rat pheochromocytoma cells (PC12).
Q J Exp Physiol 74:671–679
57. Zhang KZ, Westberg JA, Paetau A, von Boguslawsky K,
Lindsberg P, Erlander M, Guo H, Su J, Olsen HS, Anders-
son LC 1998 High expression of stanniocalcin in differenti-
ated brain neurons. Am J Pathol 153:439–445
58. Wong CK, Yeung HY, Mak NK, DiMattia GE, Chan DK,
Wagner GF 2002 Effects of dibutyryl cAMPon stanniocalcin
and stanniocalcin-related protein mRNA expression in neu-
roblastoma cells. J Endocrinol 173:199–209
59. Westberg JA, SerlachiusM, Lankila P, PenkowaM, Hidalgo
J, Andersson LC 2007 Hypoxic preconditioning induces
neuroprotective stanniocalcin-1 in brain via IL-6 signaling.
Stroke 38:1025–1030
60. Ehrhart J, Gluck M, Mieyal J, Zeevalk GD 2002 Functional
glutaredoxin (thioltransferase) activity in rat brain and liver
mitochondria. Parkinsonism Relat Disord 8:395–400
61. Watanabe E, Fujikawa A,Matsunaga H, Yasoshima Y, Sako
N, Yamamoto T, Saegusa C, Noda M 2000 Nav2/NaG
channel is involved in control of salt-intake behavior in the
CNS. J Neurosci 20:7743–7751
62. Kujubu DA, Lim RW, Varnum BC, Herschman HR 1987
Induction of transiently expressed genes in PC-12 pheo-
chromocytoma cells. Oncogene 1:257–262
63. Federoff HJ, Grabczyk E, FishmanMC1988Dual regulation
of GAP-43 gene expression by nerve growth factor and
glucocorticoids. J Biol Chem 263:19290–19295
64. Jacovina AT, Zhong F, Khazanova E, Lev E, Deora
AB, Hajjar KA 2001 Neuritogenesis and the nerve growth
factor-induced differentiation of PC-12 cells requires an-
nexin II-mediated plasmin generation. J Biol Chem 276:
49350–49358
65. Hajjar KA, Jacovina AT, Chacko J 1994 An endothelial cell
receptor for plasminogen/tissue plasminogen activator. I.
Identity with annexin II. J Biol Chem 269:21191–21197
66. Cesarman GM, Guevara CA, Hajjar KA 1994 An endothelial
cell receptor for plasminogen/tissue plasminogen activator
(t-PA). II. Annexin II-mediated enhancement of t-PA-
dependent plasminogen activation. J Biol Chem 269:
21198–21203
67. Luo W, Wickramasinghe SR, Savitt JM, Griffin JW, Dawson
TM, Ginty DD 2007 A hierarchical NGF signaling cascade
controls Ret-dependent and Ret-independent events dur-
ing development of nonpeptidergic DRG neurons. Neuron
54:739–754
68. Hayden SM, Seeds NW 1996 Modulated expression of
plasminogen activator system components in cultured cells
from dissociated mouse dorsal root ganglia. J Neurosci
16:2307–2317
69. Siconolfi LB, Seeds NW 2001 Mice lacking tPA, uPA, or
plasminogen genes showed delayed functional recovery
after sciatic nerve crush. J Neurosci 21:4348–4355
Chen et al. • Analysis of Genes Sensitive to NGF and SH2B1 Mol Endocrinol, February 2008, 22(2):454–476 475
22, 2008 
 at Case Western Reserve Univ Cleveland Health Science Lib on Februarymend.endojournals.orgDownloaded from 
70. Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels
JL, Levitt P 2003 Genetic disruption of cortical interneuron
development causes region- and GABA cell type-specific
deficits, epilepsy, and behavioral dysfunction. J Neurosci
23:622–631
71. Levitt P 2005 Disruption of interneuron development. Epi-
lepsia 46 (Suppl. 7):22–28
72. Machida CM, Rodland KD, Matrisian L, Magun BE, Ciment
G 1989 NGF induction of the gene encoding the protease
transin accompanies neuronal differentiation in PC12 cells.
Neuron 2:1587–1596
73. Seeds NW, Siconolfi LB, Haffke SP 1997 Neuronal extra-
cellular proteases facilitate cell migration, axonal growth,
and pathfinding. Cell Tissue Res 290:367–370
74. Muir D 1994 Metalloproteinase-dependent neurite out-
growth within a synthetic extracellular matrix is induced by
nerve growth factor. Exp Cell Res 210:243–252
75. Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR
1997 Urokinase receptor is associated with the compo-
nents of the JAK1/STAT1 signaling pathway and leads to
activation of this pathway upon receptor clustering in the
human kidney epithelial tumor cell line TCL-598. J Biol
Chem 272:28563–28567
76. Nguyen JT, Turck CW, Cohen FE, Zuckermann RN, LimWA
1998 Exploiting the basis of proline recognition by SH3 and
WW domains: design of N-substituted inhibitors. Science
282:2088–2092
77. Resnati M, GuttingerM, Valcamonica S, Sidenius N, Blasi F,
Fazioli F 1996 Proteolytic cleavage of the urokinase recep-
tor substitutes for the agonist-induced chemotactic effect.
EMBO J 15:1572–1582
78. Busso N, Masur SK, Lazega D, Waxman S, Ossowski L
1994 Induction of cell migration by pro-urokinase binding to
its receptor: possible mechanism for signal transduction in
human epithelial cells. J Cell Biol 126:259–270
79. Del RossoM, Anichini E, PedersenN, Blasi F, Fibbi G, Pucci
M, Ruggiero M 1993 Urokinase-urokinase receptor
interaction: non-mitogenic signal transduction in human
epidermal cells. Biochem Biophys Res Commun 190:
347–352
80. Anichini E, Zamperini A, Chevanne M, Caldini R, Pucci M,
Fibbi G, Del Rosso M 1997 Interaction of urokinase-type
plasminogen activator with its receptor rapidly induces ac-
tivation of glucose transporters. Biochem 36:3076–3083
81. Goretzki L, Mueller BM 1997 Receptor-mediated endocy-
tosis of urokinase-type plasminogen activator is regulated
by cAMP-dependent protein kinase. J Cell Sci 110(Pt 12):
1395–1402
82. Cao D, Mizukami IF, Garni-Wagner BA, Kindzelskii AL,
Todd III RF, Boxer LA, Petty HR 1995 Human urokinase-
type plasminogen activator primes neutrophils for superox-
ide anion release. Possible roles of complement receptor
type 3 and calcium. J Immunol 154:1817–1829
83. Vilhardt F, Nielsen M, Sandvig K, van Deurs B 1999 Uroki-
nase-type plasminogen activator receptor is internalized by
different mechanisms in polarized and nonpolarizedMadin-
Darby canine kidney epithelial cells. Mol Biol Cell 10:
179–195
84. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA 1999 A role
for caveolin and the urokinase receptor in integrin-mediated
adhesion and signaling. J Cell Biol 144:1285–1294
85. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S,
Doyle MV, Chapman HA 1996 Regulation of integrin func-
tion by the urokinase receptor. Science 273:1551–1555
86. McFarlane S 2003 Metalloproteases: carving out a role in
axon guidance. Neuron 37:559–562
87. VanSaunMN,Matrisian LM 2006Matrix metalloproteinases
and cellular motility in development and disease. Birth De-
fects Res C Embryo Today 78:69–79
88. Wetzel M, Rosenberg GA, Cunningham LA 2003 Tissue
inhibitor of metalloproteinases-3 andmatrix metalloprotein-
ase-3 regulate neuronal sensitivity to doxorubicin-induced
apoptosis. Eur J Neurosci 18:1050–1060
89. Su F, Kozak KR, Herschman H, Reddy ST, Farias-Eisner R
2007 Characterization of the rat urokinase plasminogen
activator receptor promoter in PC12 cells. J Neurosci Res
85:1952–1958
90. Zhang Y, ZhuW,Wang YG, Liu XJ, Jiao L, Liu X, Zhang ZH,
Lu CL, He C 2006 Interaction of SH2-B with RET is in-
volved in signaling of GDNF-induced neurite outgrowth.
J Cell Sci 119:1666–1676
91. Duan C, Li M, Rui L 2004 SH2-B promotes insulin receptor
substrate 1 (IRS1)- and IRS2-mediated activation of the
phosphatidylinositol 3-kinase pathway in response to lep-
tin. J Biol Chem 279:43684–43691
92. Rabbani SA, Gladu J 2002Urokinase receptor antibody can
reduce tumor volume and detect the presence of occult
tumor metastases in vivo. Cancer Res 62:2390–2397
93. Kendziorski CM, Zhang Y, Lan H, Attie AD 2003 The effi-
ciency of pooling mRNA in microarray experiments. Biosta-
tistics 4:465–477
94. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN
2005 On the utility of pooling biological samples in microar-
ray experiments. Proc Nat Acad Sci USA 102:4252–4257
Molecular Endocrinology is published monthly by The Endocrine Society (http://www.endo-society.org), the foremost
professional society serving the endocrine community.
476 Mol Endocrinol, February 2008, 22(2):454–476 Chen et al. • Analysis of Genes Sensitive to NGF and SH2B1
22, 2008 
 at Case Western Reserve Univ Cleveland Health Science Lib on Februarymend.endojournals.orgDownloaded from 
